Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type|Pathology location|Pathology Description|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-1|1|109|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-2|1|109|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-3|1|113|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-4|1|118|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-5|1|142|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-6|1|157|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYB,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-7|1|164|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-8|1|178|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-9|1|190|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-10|1|208|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-11|1|210|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-12|1|217|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-13|1|219|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-14|1|228|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-15|1|259|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-16|1|288|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-17|1|294|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-18|1|296|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-19|1|318|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-20|1|347|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-21|1|356|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-22|1|356|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-23|1|356|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-24|1|356|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-25|1|356|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-26|1|356|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-27|1|356|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-28|1|358|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-29|1|389|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-30|1|399|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-31|1|413|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-32|1|413|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-33|1|413|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-34|1|413|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-35|1|413|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-36|1|413|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-37|1|413|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-38|1|420|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBON|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-39|1|431|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LUK,MPATH: 335 - hematopoietic/lymphoid malignancies/disorder|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-40|1|434|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LUK,MPATH: 335 - hematopoietic/lymphoid malignancies/disorder|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-41|1|438|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-42|1|442|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-43|1|442|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-44|1|442|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-45|1|442|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-46|1|442|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-47|1|443|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-48|1|443|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-49|1|455|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-50|1|457|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-51|1|461|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-52|1|470|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-53|1|473|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TUT,MPATH: 268 - adenocarcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-54|1|484|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-55|1|487|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-56|1|488|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-57|1|489|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-58|1|493|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-59|1|495|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-60|1|497|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-61|1|499|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-62|1|504|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-63|1|504|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-64|1|505|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-65|1|505|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-66|1|505|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-67|1|512|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-68|1|512|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-69|1|513|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-70|1|514|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-71|1|514|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-72|1|520|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-73|1|521|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-74|1|526|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-75|1|526|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-76|1|527|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-77|1|528|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-78|1|531|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LSAR,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-79|1|532|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-80|1|532|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-81|1|533|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-82|1|538|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-83|1|539|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-84|1|539|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-85|1|545|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-86|1|546|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-87|1|548|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-88|1|554|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-89|1|556|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-90|1|557|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYB,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-91|1|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-92|1|563|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-93|1|563|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-94|1|566|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-95|1|567|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-96|1|567|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-97|1|568|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-98|1|575|Neoplasia benign|Endocrine system|THARA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-99|1|577|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-100|1|579|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-101|1|579|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-102|1|581|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-103|1|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-104|1|582|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-105|1|587|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-106|1|588|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-107|1|589|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-108|1|589|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-109|1|589|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-110|1|589|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-111|1|593|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-112|1|594|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-113|1|594|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-114|1|595|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-115|1|595|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-116|1|596|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-117|1|599|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-118|1|599|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-119|1|600|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-120|1|602|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-121|1|602|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-122|1|602|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-123|1|604|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-124|1|604|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-125|1|604|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-126|1|604|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-127|1|607|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-128|1|608|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-129|1|609|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYB,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-130|1|609|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-131|1|609|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-132|1|609|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|TADR,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-133|1|610|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-134|1|610|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-135|1|611|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-136|1|613|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-137|1|615|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-138|1|616|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-139|1|616|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-140|1|616|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-141|1|617|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-142|1|617|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-143|1|617|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-144|1|618|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-145|1|618|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-146|1|619|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-147|1|620|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-148|1|620|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-149|1|620|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-150|1|621|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-151|1|621|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-152|1|621|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-153|1|621|Neoplasia benign|Liver among hepato-pancreatic system diseases|THEP|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-154|1|621|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-155|1|622|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-156|1|623|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-157|1|623|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-158|1|624|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-159|1|624|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-160|1|624|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-161|1|624|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-162|1|627|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-163|1|629|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-164|1|629|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-165|1|631|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-166|1|631|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-167|1|631|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LSAR,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-168|1|631|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-169|1|632|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-170|1|633|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-171|1|634|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-172|1|635|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-173|1|635|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-174|1|636|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-175|1|637|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-176|1|638|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-177|1|639|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-178|1|641|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-179|1|641|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-180|1|642|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-181|1|642|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-182|1|643|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-183|1|644|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-184|1|645|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-185|1|645|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-186|1|647|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-187|1|649|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-188|1|650|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-189|1|650|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-190|1|651|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-191|1|651|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-192|1|652|Neoplasia benign|Bloodvessels among cardiovascular system|TVASH|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-193|1|652|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-194|1|654|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-195|1|654|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-196|1|654|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-197|1|656|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-198|1|657|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TUT,MPATH: 268 - adenocarcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-199|1|658|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-200|1|658|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-201|1|659|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-202|1|660|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-203|1|660|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-204|1|660|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-205|1|660|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-206|1|661|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-207|1|662|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYB,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-208|1|663|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-209|1|664|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-210|1|665|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-211|1|665|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-212|1|665|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-213|1|667|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-214|1|669|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-215|1|672|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-216|1|672|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-217|1|672|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-218|1|672|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-219|1|673|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-220|1|677|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-221|1|677|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-222|1|679|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-223|1|679|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-224|1|680|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-225|1|680|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-226|1|680|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-227|1|681|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-228|1|682|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LSAR,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-229|1|683|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-230|1|684|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-231|1|686|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-232|1|686|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-233|1|686|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-234|1|686|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-235|1|687|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-236|1|688|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-237|1|688|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-238|1|691|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-239|1|692|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-240|1|693|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-241|1|693|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-242|1|693|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-243|1|694|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-244|1|694|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-245|1|694|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-246|1|694|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-247|1|694|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-248|1|694|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-249|1|694|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-250|1|694|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-251|1|695|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-252|1|695|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-253|1|695|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-254|1|695|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-255|1|697|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-256|1|697|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-257|1|699|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-258|1|699|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-259|1|700|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-260|1|700|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-261|1|700|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-262|1|701|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-263|1|701|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-264|1|702|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-265|1|702|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-266|1|702|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-267|1|702|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-268|1|703|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-269|1|705|Neoplasia benign|Bloodvessels among cardiovascular system|TVASH|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-270|1|706|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-271|1|706|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-272|1|706|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-273|1|707|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-274|1|707|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-275|1|707|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-276|1|707|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-277|1|709|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYB,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-278|1|710|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-279|1|712|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-280|1|712|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-281|1|713|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-282|1|714|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-283|1|715|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-284|1|716|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LSAR,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-285|1|716|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-286|1|716|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-287|1|717|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-288|1|719|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-289|1|720|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-290|1|720|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-291|1|721|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-292|1|721|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-293|1|722|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-294|1|722|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-295|1|723|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-296|1|724|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-297|1|724|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-298|1|724|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-299|1|725|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-300|1|726|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-301|1|727|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-302|1|727|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-303|1|728|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-304|1|728|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-305|1|729|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-306|1|730|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-307|1|730|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-308|1|731|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-309|1|731|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-310|1|731|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-311|1|731|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-312|1|731|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-313|1|731|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-314|1|731|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-315|1|731|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-316|1|731|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-317|1|732|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-318|1|732|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-319|1|732|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-320|1|733|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-321|1|733|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-322|1|733|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-323|1|734|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-324|1|735|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-325|1|735|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-326|1|735|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-327|1|735|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-328|1|735|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|TADR,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-329|1|736|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-330|1|736|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-331|1|738|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-332|1|738|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-333|1|738|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-334|1|740|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-335|1|741|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-336|1|742|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-337|1|742|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-338|1|742|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-339|1|742|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-340|1|742|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-341|1|743|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-342|1|743|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-343|1|743|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-344|1|744|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-345|1|744|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-346|1|745|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-347|1|745|Neoplasia benign|Liver among hepato-pancreatic system diseases|THEP|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-348|1|745|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-349|1|745|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-350|1|749|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-351|1|749|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-352|1|749|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-353|1|749|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-354|1|749|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-355|1|749|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-356|1|749|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-357|1|749|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-358|1|749|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-359|1|750|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-360|1|750|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-361|1|751|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-362|1|751|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-363|1|751|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-364|1|751|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-365|1|751|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-366|1|751|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-367|1|752|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-368|1|752|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-369|1|754|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-370|1|754|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-371|1|754|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-372|1|754|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-373|1|755|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-374|1|755|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-375|1|755|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-376|1|756|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-377|1|756|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-378|1|756|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-379|1|757|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-380|1|757|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-381|1|757|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-382|1|758|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-383|1|758|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-384|1|760|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-385|1|762|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-386|1|762|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-387|1|762|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-388|1|762|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-389|1|763|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LSAR,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-390|1|763|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-391|1|763|Neoplasia benign|Liver among hepato-pancreatic system diseases|THEP|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-392|1|764|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-393|1|764|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-394|1|764|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-395|1|764|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-396|1|764|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-397|1|764|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-398|1|765|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-399|1|765|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-400|1|765|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-401|1|765|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-402|1|766|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-403|1|766|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-404|1|766|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-405|1|767|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-406|1|767|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-407|1|768|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-408|1|769|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-409|1|770|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-410|1|770|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-411|1|770|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-412|1|772|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-413|1|773|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-414|1|773|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-415|1|773|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-416|1|776|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-417|1|776|Neoplasia malignant|Endocrine system|THARC|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-418|1|776|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-419|1|776|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-420|1|776|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-421|1|777|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-422|1|777|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-423|1|777|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-424|1|778|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-425|1|779|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-426|1|779|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-427|1|780|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-428|1|780|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-429|1|781|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-430|1|781|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-431|1|782|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-432|1|783|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-433|1|783|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-434|1|783|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-435|1|783|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-436|1|784|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-437|1|784|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-438|1|784|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-439|1|784|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-440|1|784|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-441|1|784|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-442|1|785|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-443|1|785|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-444|1|786|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-445|1|786|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-446|1|787|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-447|1|787|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-448|1|787|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TUT,MPATH: 268 - adenocarcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-449|1|787|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-450|1|787|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-451|1|788|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-452|1|790|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-453|1|790|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-454|1|791|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-455|1|792|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-456|1|792|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-457|1|792|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-458|1|793|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-459|1|793|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-460|1|794|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|TADR,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-461|1|794|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-462|1|794|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-463|1|794|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-464|1|794|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-465|1|797|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-466|1|797|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-467|1|798|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-468|1|798|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-469|1|798|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-470|1|799|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-471|1|799|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-472|1|799|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-473|1|800|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-474|1|800|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-475|1|800|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-476|1|800|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-477|1|800|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-478|1|801|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-479|1|801|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-480|1|801|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-481|1|804|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-482|1|804|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-483|1|805|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-484|1|805|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-485|1|806|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LSAR,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-486|1|806|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-487|1|806|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-488|1|806|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-489|1|808|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-490|1|811|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-491|1|811|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-492|1|811|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-493|1|812|Neoplasia benign|Liver among hepato-pancreatic system diseases|THEP|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-494|1|812|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-495|1|812|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-496|1|813|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-497|1|813|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-498|1|813|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-499|1|814|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-500|1|814|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-501|1|814|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-502|1|814|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-503|1|814|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-504|1|815|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-505|1|816|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-506|1|819|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-507|1|819|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-508|1|820|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-509|1|820|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-510|1|820|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-511|1|820|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-512|1|821|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-513|1|821|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-514|1|822|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-515|1|822|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-516|1|824|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-517|1|824|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-518|1|825|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-519|1|825|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-520|1|825|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-521|1|826|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-522|1|826|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-523|1|827|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-524|1|827|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-525|1|827|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-526|1|827|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-527|1|827|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-528|1|827|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-529|1|829|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-530|1|829|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-531|1|831|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-532|1|831|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-533|1|831|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|TADR,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-534|1|832|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-535|1|832|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-536|1|832|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-537|1|833|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-538|1|833|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-539|1|833|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-540|1|833|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-541|1|833|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-542|1|834|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-543|1|835|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-544|1|836|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-545|1|838|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-546|1|838|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-547|1|839|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-548|1|840|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-549|1|840|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-550|1|841|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-551|1|841|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-552|1|841|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-553|1|841|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-554|1|842|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-555|1|842|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-556|1|842|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-557|1|842|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-558|1|842|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-559|1|844|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-560|1|844|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-561|1|845|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-562|1|845|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-563|1|845|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-564|1|846|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-565|1|846|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-566|1|847|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-567|1|847|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|TADR,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-568|1|847|Neoplasia benign|Bloodvessels among cardiovascular system|TVASH|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-569|1|847|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TUT,MPATH: 268 - adenocarcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-570|1|848|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-571|1|848|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-572|1|849|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-573|1|849|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-574|1|849|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-575|1|852|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-576|1|852|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-577|1|852|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-578|1|853|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-579|1|853|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-580|1|854|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-581|1|854|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-582|1|855|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-583|1|857|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-584|1|858|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-585|1|858|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-586|1|858|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-587|1|858|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-588|1|859|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-589|1|859|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-590|1|860|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-591|1|860|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-592|1|860|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-593|1|862|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LSAR,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-594|1|863|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-595|1|863|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-596|1|864|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-597|1|866|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-598|1|866|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-599|1|866|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-600|1|867|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-601|1|868|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-602|1|868|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-603|1|869|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-604|1|869|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-605|1|869|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-606|1|870|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-607|1|871|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-608|1|873|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-609|1|873|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-610|1|873|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-611|1|873|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-612|1|873|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-613|1|873|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-614|1|873|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-615|1|875|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-616|1|875|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-617|1|878|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-618|1|878|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-619|1|880|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-620|1|880|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-621|1|881|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-622|1|881|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-623|1|881|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-624|1|882|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-625|1|882|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-626|1|882|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-627|1|883|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-628|1|883|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-629|1|883|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-630|1|884|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-631|1|884|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-632|1|885|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-633|1|886|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-634|1|888|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-635|1|889|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-636|1|889|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-637|1|889|Neoplasia malignant|Adrenal gland  among endocrine systems|TADRC|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-638|1|890|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-639|1|890|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-640|1|890|Neoplasia benign|Liver among hepato-pancreatic system diseases|THEP|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-641|1|890|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-642|1|891|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-643|1|891|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-644|1|892|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-645|1|892|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-646|1|894|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-647|1|894|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-648|1|894|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-649|1|895|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-650|1|897|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-651|1|898|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-652|1|898|Neoplasia malignant|Upper digestive tract,MA: 0000341 - oral region|TSQC,MPATH: 446 - squamous cell carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-653|1|899|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-654|1|901|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-655|1|901|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-656|1|903|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-657|1|903|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-658|1|903|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-659|1|903|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-660|1|903|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-661|1|904|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-662|1|904|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-663|1|904|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-664|1|905|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-665|1|905|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-666|1|905|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-667|1|905|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-668|1|905|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-669|1|907|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-670|1|908|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-671|1|908|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-672|1|909|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-673|1|910|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-674|1|910|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-675|1|912|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-676|1|912|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-677|1|912|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-678|1|915|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYB,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-679|1|915|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-680|1|916|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-681|1|916|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-682|1|916|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-683|1|916|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-684|1|917|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-685|1|917|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-686|1|917|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-687|1|918|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-688|1|918|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-689|1|919|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-690|1|921|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-691|1|923|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-692|1|924|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-693|1|925|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-694|1|925|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-695|1|926|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-696|1|928|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-697|1|928|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-698|1|929|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-699|1|929|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-700|1|929|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|TADR,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-701|1|930|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-702|1|930|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-703|1|930|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-704|1|931|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-705|1|931|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-706|1|931|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-707|1|931|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-708|1|931|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-709|1|932|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-710|1|932|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-711|1|933|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-712|1|934|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-713|1|936|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-714|1|936|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-715|1|938|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-716|1|938|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-717|1|938|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-718|1|940|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-719|1|940|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-720|1|941|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-721|1|943|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-722|1|944|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-723|1|947|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-724|1|947|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-725|1|948|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-726|1|950|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-727|1|950|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-728|1|951|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-729|1|951|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-730|1|951|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-731|1|951|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-732|1|952|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-733|1|957|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-734|1|959|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-735|1|960|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-736|1|965|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-737|1|965|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-738|1|966|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-739|1|967|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-740|1|967|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-741|1|968|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-742|1|971|Neoplasia malignant|Adrenal gland  among endocrine systems|TADRC|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-743|1|971|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-744|1|971|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-745|1|971|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-746|1|974|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-747|1|976|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-748|1|978|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-749|1|978|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-750|1|979|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-751|1|981|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-752|1|982|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-753|1|982|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-754|1|983|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|TADR,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-755|1|983|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-756|1|984|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-757|1|984|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-758|1|986|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-759|1|987|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-760|1|987|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-761|1|989|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-762|1|990|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-763|1|990|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-764|1|993|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TOTH,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-765|1|993|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-766|1|994|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|TADR,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-767|1|995|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-768|1|995|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-769|1|995|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-770|1|999|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-771|1|1001|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-772|1|1003|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-773|1|1007|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-774|1|1008|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-775|1|1009|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-776|1|1013|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-777|1|1014|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-778|1|1015|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-779|1|1016|Other deterministic changes|Whole body|NVL|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-780|1|1019|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-781|1|1020|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-782|1|1020|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-783|1|1021|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-784|1|1021|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-785|1|1021|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-786|1|1023|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-787|1|1023|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|TADR,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-788|1|1023|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-789|1|1025|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-790|1|1028|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-791|1|1031|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-792|1|1035|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-793|1|1037|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-794|1|1039|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-795|1|1041|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-796|1|1043|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-797|1|1043|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-798|1|1044|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-799|1|1044|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|TADR,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-800|1|1045|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-801|1|1049|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-802|1|1050|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-803|1|1053|Neoplasia benign|Bloodvessels among cardiovascular system|TVASH|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-804|1|1054|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-805|1|1056|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-806|1|1058|Neoplasia malignant|Adrenal gland  among endocrine systems|TADRC|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-807|1|1059|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-808|1|1060|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-809|1|1066|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-810|1|1069|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-811|1|1069|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-812|1|1072|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LSAR,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-813|1|1085|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-814|1|1086|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-815|1|1093|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-816|1|1098|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-817|1|1099|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-818|1|1102|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-819|1|1105|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-820|1|1107|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-821|1|1108|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-822|1|1109|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-823|1|1119|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-824|1|1126|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-825|1|1129|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-826|1|1139|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-827|1|1151|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-828|1|1154|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-829|1|1156|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-830|1|1157|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-831|1|1183|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|TADR,MPATH: 549 - carcinoma|
1007-1-1|BALB/cBd female mice control group,BALB0A|1|70|none (controls)|0|grays|External exposure|Single exposure|832 (832 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-1-832|1|1204|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-833|2|116|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-834|2|119|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-835|2|120|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-836|2|120|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-837|2|123|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-838|2|124|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-839|2|142|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-840|2|146|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-841|2|154|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-842|2|157|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-843|2|168|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-844|2|193|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-845|2|197|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-846|2|197|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-847|2|207|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-848|2|209|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-849|2|211|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-850|2|217|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-851|2|218|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-852|2|238|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-853|2|268|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-854|2|274|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-855|2|284|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-856|2|293|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-857|2|304|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-858|2|308|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-859|2|309|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-860|2|329|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-861|2|333|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-862|2|336|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-863|2|342|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-864|2|344|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-865|2|344|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-866|2|352|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-867|2|353|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-868|2|358|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-869|2|360|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-870|2|364|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-871|2|365|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-872|2|367|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-873|2|372|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-874|2|372|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-875|2|373|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-876|2|379|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-877|2|386|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-878|2|386|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-879|2|387|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-880|2|388|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-881|2|394|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-882|2|396|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-883|2|398|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-884|2|406|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-885|2|407|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-886|2|416|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-887|2|420|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-888|2|428|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-889|2|429|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-890|2|429|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-891|2|436|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-892|2|437|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-893|2|441|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-894|2|442|Neoplasia malignant|Upper digestive tract,MA: 0000341 - oral region|TSQC,MPATH: 446 - squamous cell carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-895|2|444|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LSAR,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-896|2|445|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-897|2|448|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-898|2|451|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-899|2|460|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-900|2|462|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-901|2|463|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-902|2|464|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-903|2|465|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-904|2|468|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-905|2|468|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-906|2|470|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-907|2|470|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-908|2|470|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-909|2|472|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-910|2|472|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-911|2|474|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-912|2|476|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-913|2|476|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-914|2|483|Neoplasia benign|Liver among hepato-pancreatic system diseases|THEP|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-915|2|484|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-916|2|484|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-917|2|485|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-918|2|490|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-919|2|491|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-920|2|492|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-921|2|493|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-922|2|493|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-923|2|496|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-924|2|497|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TOTH,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-925|2|497|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-926|2|498|Neoplasia systemic|Haematolymphatic system|LMON|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-927|2|498|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-928|2|506|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-929|2|507|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-930|2|507|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-931|2|511|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-932|2|513|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-933|2|515|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-934|2|516|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-935|2|518|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|TADR,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-936|2|521|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYB,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-937|2|521|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LSAR,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-938|2|523|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-939|2|525|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-940|2|526|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-941|2|531|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-942|2|532|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-943|2|537|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-944|2|538|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-945|2|539|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-946|2|539|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-947|2|539|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-948|2|540|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-949|2|540|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-950|2|541|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-951|2|542|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-952|2|545|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-953|2|548|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-954|2|549|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-955|2|549|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-956|2|552|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-957|2|552|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-958|2|554|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-959|2|555|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-960|2|555|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-961|2|558|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-962|2|559|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-963|2|560|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-964|2|561|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-965|2|562|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-966|2|563|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-967|2|565|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-968|2|565|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-969|2|566|Neoplasia malignant|Upper digestive tract,MA: 0000341 - oral region|TSQC,MPATH: 446 - squamous cell carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-970|2|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-971|2|569|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-972|2|570|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-973|2|570|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-974|2|570|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-975|2|572|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-976|2|573|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-977|2|574|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-978|2|574|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-979|2|575|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-980|2|576|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-981|2|577|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LSAR,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-982|2|579|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-983|2|580|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-984|2|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-985|2|582|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-986|2|582|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-987|2|582|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-988|2|583|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-989|2|584|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-990|2|584|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-991|2|584|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-992|2|585|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-993|2|586|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-994|2|587|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-995|2|587|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-996|2|589|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-997|2|589|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-998|2|590|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-999|2|591|Neoplasia benign|Endocrine system|THARA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1000|2|591|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1001|2|592|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1002|2|593|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1003|2|594|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1004|2|595|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1005|2|596|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1006|2|596|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1007|2|597|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1008|2|598|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1009|2|598|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1010|2|599|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1011|2|601|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1012|2|601|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1013|2|601|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1014|2|601|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1015|2|602|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1016|2|603|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1017|2|604|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1018|2|604|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1019|2|605|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1020|2|605|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1021|2|605|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1022|2|608|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1023|2|608|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1024|2|609|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1025|2|609|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1026|2|610|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1027|2|610|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1028|2|611|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1029|2|611|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1030|2|611|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1031|2|611|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1032|2|614|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1033|2|614|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1034|2|615|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1035|2|617|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1036|2|617|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1037|2|617|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1038|2|618|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1039|2|618|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1040|2|618|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1041|2|618|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1042|2|619|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1043|2|619|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1044|2|619|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1045|2|620|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1046|2|621|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1047|2|621|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1048|2|622|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1049|2|622|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1050|2|622|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1051|2|622|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1052|2|623|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1053|2|623|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1054|2|624|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1055|2|624|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1056|2|624|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1057|2|624|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1058|2|624|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1059|2|626|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1060|2|627|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1061|2|628|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1062|2|628|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1063|2|628|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1064|2|628|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1065|2|629|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1066|2|629|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1067|2|629|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1068|2|629|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1069|2|629|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1070|2|630|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1071|2|630|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1072|2|631|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1073|2|631|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1074|2|632|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1075|2|632|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1076|2|632|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1077|2|633|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1078|2|634|Neoplasia unclassified|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|TPAN,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1079|2|635|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1080|2|636|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1081|2|637|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1082|2|638|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1083|2|638|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1084|2|638|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1085|2|638|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1086|2|640|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1087|2|640|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1088|2|642|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1089|2|642|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1090|2|642|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1091|2|642|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1092|2|643|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1093|2|643|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1094|2|644|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1095|2|645|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1096|2|645|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1097|2|645|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1098|2|645|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1099|2|646|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1100|2|648|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1101|2|649|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1102|2|649|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1103|2|649|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1104|2|650|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1105|2|650|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1106|2|650|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1107|2|651|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1108|2|651|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1109|2|651|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1110|2|651|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1111|2|651|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1112|2|652|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1113|2|652|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1114|2|653|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1115|2|654|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1116|2|655|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1117|2|658|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1118|2|658|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1119|2|658|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1120|2|658|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1121|2|660|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1122|2|660|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1123|2|660|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1124|2|660|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1125|2|661|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1126|2|662|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1127|2|664|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1128|2|664|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1129|2|665|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1130|2|665|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1131|2|666|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LSAR,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1132|2|666|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1133|2|666|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1134|2|666|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1135|2|667|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1136|2|667|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1137|2|668|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1138|2|668|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1139|2|669|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1140|2|670|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1141|2|670|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1142|2|671|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1143|2|671|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1144|2|672|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1145|2|672|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1146|2|672|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1147|2|673|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1148|2|673|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1149|2|673|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1150|2|673|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1151|2|674|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1152|2|676|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1153|2|678|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1154|2|679|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1155|2|679|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1156|2|679|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1157|2|679|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1158|2|679|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1159|2|679|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1160|2|680|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1161|2|680|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|TADR,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1162|2|680|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1163|2|681|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1164|2|681|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1165|2|681|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1166|2|682|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1167|2|683|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1168|2|683|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1169|2|684|Neoplasia benign|Liver among hepato-pancreatic system diseases|THEP|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1170|2|684|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1171|2|684|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1172|2|684|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1173|2|685|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1174|2|685|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1175|2|685|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1176|2|686|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1177|2|686|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1178|2|686|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1179|2|686|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1180|2|686|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1181|2|687|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1182|2|687|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1183|2|687|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1184|2|688|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1185|2|689|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1186|2|689|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1187|2|690|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1188|2|692|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1189|2|692|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1190|2|693|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1191|2|694|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1192|2|694|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1193|2|694|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1194|2|694|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1195|2|695|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1196|2|695|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1197|2|695|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1198|2|696|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1199|2|698|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1200|2|699|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1201|2|699|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1202|2|699|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1203|2|699|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1204|2|700|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1205|2|700|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1206|2|700|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LSAR,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1207|2|701|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1208|2|701|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1209|2|701|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1210|2|701|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1211|2|701|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1212|2|701|Neoplasia malignant|Adrenal gland  among endocrine systems|TADRC|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1213|2|702|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1214|2|703|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1215|2|703|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1216|2|703|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1217|2|705|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1218|2|707|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1219|2|707|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1220|2|707|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1221|2|708|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1222|2|708|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1223|2|709|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1224|2|709|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1225|2|709|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1226|2|710|Neoplasia benign|Endocrine system|THARA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1227|2|714|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1228|2|714|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1229|2|714|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1230|2|715|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1231|2|715|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1232|2|716|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1233|2|717|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1234|2|720|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1235|2|721|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1236|2|721|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1237|2|721|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1238|2|722|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1239|2|723|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1240|2|724|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|TADR,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1241|2|724|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1242|2|725|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1243|2|727|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1244|2|728|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1245|2|728|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1246|2|728|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1247|2|729|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LSAR,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1248|2|729|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1249|2|729|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1250|2|730|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1251|2|730|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1252|2|730|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1253|2|730|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1254|2|731|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1255|2|732|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1256|2|734|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1257|2|734|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1258|2|734|Neoplasia benign|Liver among hepato-pancreatic system diseases|THEP|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1259|2|734|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1260|2|735|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1261|2|735|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1262|2|736|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1263|2|736|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1264|2|736|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1265|2|736|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1266|2|737|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1267|2|737|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1268|2|737|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1269|2|737|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1270|2|738|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1271|2|738|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1272|2|739|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1273|2|741|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1274|2|741|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1275|2|741|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1276|2|744|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1277|2|745|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1278|2|745|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1279|2|746|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1280|2|746|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1281|2|746|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1282|2|747|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1283|2|747|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1284|2|747|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1285|2|748|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1286|2|748|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1287|2|748|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1288|2|748|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1289|2|748|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1290|2|749|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1291|2|749|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1292|2|749|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1293|2|749|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1294|2|750|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1295|2|751|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1296|2|751|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1297|2|751|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1298|2|751|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1299|2|752|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1300|2|752|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1301|2|753|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1302|2|755|Neoplasia malignant|Adrenal gland  among endocrine systems|TADRC|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1303|2|755|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1304|2|756|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1305|2|756|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1306|2|756|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1307|2|757|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1308|2|757|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1309|2|757|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1310|2|758|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1311|2|758|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1312|2|758|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1313|2|758|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1314|2|759|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1315|2|761|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1316|2|761|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1317|2|762|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1318|2|762|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1319|2|763|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1320|2|763|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1321|2|764|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1322|2|764|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1323|2|764|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1324|2|764|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1325|2|764|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1326|2|764|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1327|2|764|Neoplasia malignant|Upper digestive tract,MA: 0000341 - oral region|TSQC,MPATH: 446 - squamous cell carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1328|2|765|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1329|2|765|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1330|2|765|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1331|2|765|Neoplasia malignant|Upper digestive tract,MA: 0000341 - oral region|TSQC,MPATH: 446 - squamous cell carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1332|2|765|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1333|2|766|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1334|2|766|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1335|2|766|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1336|2|767|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1337|2|768|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1338|2|768|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1339|2|768|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1340|2|769|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1341|2|769|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1342|2|769|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1343|2|770|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1344|2|770|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1345|2|770|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1346|2|771|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1347|2|771|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1348|2|772|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1349|2|772|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1350|2|773|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1351|2|773|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1352|2|775|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1353|2|775|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1354|2|776|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1355|2|776|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1356|2|776|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1357|2|776|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1358|2|776|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1359|2|777|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1360|2|778|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1361|2|778|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1362|2|778|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1363|2|778|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1364|2|778|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1365|2|778|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1366|2|780|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1367|2|780|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1368|2|782|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1369|2|783|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1370|2|784|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1371|2|784|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1372|2|784|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1373|2|784|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1374|2|784|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1375|2|784|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1376|2|785|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1377|2|785|Neoplasia benign|Liver among hepato-pancreatic system diseases|THEP|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1378|2|786|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1379|2|787|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1380|2|787|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1381|2|787|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1382|2|787|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1383|2|790|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1384|2|790|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1385|2|790|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1386|2|790|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1387|2|790|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1388|2|790|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1389|2|790|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1390|2|791|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1391|2|791|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1392|2|791|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1393|2|791|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1394|2|791|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1395|2|791|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1396|2|791|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1397|2|792|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1398|2|793|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1399|2|794|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1400|2|794|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1401|2|794|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LSAR,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1402|2|794|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1403|2|797|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1404|2|797|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1405|2|797|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1406|2|798|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1407|2|798|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1408|2|798|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1409|2|799|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1410|2|799|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1411|2|800|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1412|2|800|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1413|2|801|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1414|2|802|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1415|2|803|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1416|2|805|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1417|2|805|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1418|2|805|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1419|2|805|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1420|2|805|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1421|2|805|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1422|2|805|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1423|2|806|Other deterministic changes|Whole body|NVL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1424|2|806|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1425|2|807|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1426|2|807|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1427|2|808|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1428|2|809|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1429|2|810|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1430|2|811|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1431|2|811|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1432|2|811|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1433|2|813|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1434|2|813|Neoplasia malignant|Upper digestive tract,MA: 0000341 - oral region|TSQC,MPATH: 446 - squamous cell carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1435|2|813|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1436|2|815|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1437|2|815|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1438|2|815|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1439|2|815|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1440|2|815|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1441|2|815|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1442|2|817|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1443|2|818|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1444|2|818|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1445|2|818|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1446|2|819|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1447|2|819|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1448|2|819|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1449|2|820|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1450|2|820|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1451|2|820|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1452|2|821|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1453|2|821|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1454|2|821|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1455|2|821|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1456|2|822|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1457|2|823|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1458|2|824|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1459|2|825|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1460|2|825|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1461|2|825|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1462|2|825|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1463|2|827|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1464|2|827|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1465|2|827|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1466|2|827|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1467|2|828|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1468|2|828|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1469|2|828|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1470|2|828|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1471|2|829|Neoplasia unclassified|Kidney among urinary system diseases,MA: 0000368 - kidney|TKID,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1472|2|829|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1473|2|831|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1474|2|832|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1475|2|833|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1476|2|835|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1477|2|835|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1478|2|835|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1479|2|839|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1480|2|840|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1481|2|840|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1482|2|842|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1483|2|842|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1484|2|842|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1485|2|845|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1486|2|845|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1487|2|845|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1488|2|846|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1489|2|846|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1490|2|846|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1491|2|846|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1492|2|847|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1493|2|847|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1494|2|847|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1495|2|848|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1496|2|848|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1497|2|849|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1498|2|850|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1499|2|852|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1500|2|852|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1501|2|852|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1502|2|853|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1503|2|853|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1504|2|854|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1505|2|855|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1506|2|856|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1507|2|859|Neoplasia malignant|Adrenal gland  among endocrine systems|TADRC|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1508|2|859|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1509|2|861|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1510|2|861|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1511|2|861|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1512|2|862|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1513|2|863|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1514|2|867|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1515|2|867|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1516|2|867|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1517|2|868|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1518|2|868|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1519|2|870|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1520|2|870|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1521|2|870|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1522|2|871|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1523|2|873|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1524|2|875|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1525|2|875|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1526|2|875|Neoplasia unclassified|Lower digestive tract,MA: 0000328 - intestine|TINT,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1527|2|875|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1528|2|876|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1529|2|876|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1530|2|877|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1531|2|880|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1532|2|881|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1533|2|882|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1534|2|882|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1535|2|882|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1536|2|883|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1537|2|884|Neoplasia malignant|Endocrine system|THARC|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1538|2|884|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1539|2|885|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1540|2|885|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1541|2|887|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1542|2|889|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1543|2|889|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1544|2|889|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1545|2|889|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1546|2|889|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1547|2|889|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1548|2|891|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1549|2|892|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1550|2|892|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1551|2|893|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1552|2|894|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1553|2|894|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1554|2|895|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1555|2|896|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1556|2|898|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1557|2|898|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1558|2|898|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1559|2|898|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1560|2|899|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1561|2|901|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1562|2|902|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1563|2|902|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1564|2|902|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1565|2|904|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1566|2|904|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1567|2|904|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1568|2|904|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1569|2|905|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1570|2|907|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1571|2|908|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1572|2|908|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1573|2|909|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1574|2|911|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1575|2|912|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1576|2|913|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1577|2|916|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1578|2|918|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1579|2|918|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1580|2|919|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1581|2|922|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1582|2|923|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1583|2|929|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1584|2|929|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1585|2|929|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1586|2|930|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1587|2|930|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1588|2|931|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1589|2|931|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1590|2|931|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1591|2|931|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1592|2|933|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1593|2|933|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1594|2|935|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1595|2|936|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1596|2|938|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1597|2|943|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1598|2|944|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1599|2|944|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1600|2|945|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1601|2|945|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1602|2|946|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1603|2|947|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1604|2|950|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1605|2|955|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1606|2|956|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1607|2|956|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1608|2|958|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1609|2|959|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1610|2|960|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1611|2|960|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1612|2|961|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1613|2|965|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1614|2|966|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1615|2|966|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1616|2|970|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1617|2|972|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1618|2|972|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1619|2|974|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1620|2|976|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1621|2|977|Neoplasia unclassified|Lower digestive tract,MA: 0000328 - intestine|TINT,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1622|2|977|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1623|2|977|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1624|2|979|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1625|2|979|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1626|2|980|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1627|2|981|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1628|2|984|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1629|2|991|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1630|2|992|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1631|2|995|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1632|2|995|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1633|2|997|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1634|2|999|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1635|2|1000|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1636|2|1003|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1637|2|1007|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1638|2|1008|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1639|2|1021|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1640|2|1022|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1641|2|1023|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1642|2|1025|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1643|2|1026|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1644|2|1028|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1645|2|1028|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1646|2|1029|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1647|2|1030|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1648|2|1036|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1649|2|1037|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1650|2|1039|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1651|2|1040|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1652|2|1041|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1653|2|1042|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1654|2|1047|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LSAR,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1655|2|1050|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1656|2|1054|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1657|2|1058|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1658|2|1065|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1659|2|1069|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1660|2|1073|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1661|2|1075|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1662|2|1083|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1663|2|1088|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1664|2|1113|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1665|2|1126|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-2|BALB/cBd female mice 0.5 Gy exposure at 10 weeks,BALB50A|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|834 (834 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-2-1666|2|1126|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1667|3|161|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1668|3|169|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1669|3|181|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1670|3|184|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1671|3|187|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1672|3|189|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1673|3|191|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1674|3|191|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1675|3|196|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1676|3|199|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1677|3|202|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1678|3|205|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1679|3|211|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1680|3|211|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1681|3|213|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1682|3|216|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1683|3|222|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1684|3|231|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1685|3|235|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1686|3|253|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1687|3|253|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1688|3|269|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1689|3|273|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1690|3|280|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1691|3|281|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1692|3|284|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1693|3|292|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1694|3|303|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1695|3|306|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1696|3|319|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1697|3|321|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1698|3|321|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1699|3|322|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1700|3|324|Neoplasia unclassified|Lower digestive tract,MA: 0000328 - intestine|TINT,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1701|3|332|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1702|3|337|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1703|3|345|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1704|3|353|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1705|3|358|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1706|3|367|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1707|3|367|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1708|3|369|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1709|3|371|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1710|3|378|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1711|3|378|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1712|3|379|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1713|3|379|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1714|3|379|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1715|3|384|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1716|3|385|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1717|3|387|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1718|3|392|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1719|3|393|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1720|3|397|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1721|3|398|Neoplasia benign|Liver among hepato-pancreatic system diseases|THEP|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1722|3|399|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1723|3|400|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1724|3|402|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1725|3|403|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1726|3|405|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1727|3|406|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1728|3|419|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1729|3|421|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1730|3|421|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1731|3|422|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1732|3|427|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1733|3|429|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1734|3|430|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1735|3|433|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1736|3|437|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1737|3|441|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1738|3|441|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1739|3|442|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1740|3|442|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1741|3|443|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1742|3|444|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1743|3|444|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1744|3|445|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1745|3|447|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1746|3|449|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1747|3|454|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1748|3|456|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1749|3|457|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1750|3|458|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1751|3|461|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1752|3|461|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1753|3|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1754|3|466|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1755|3|467|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1756|3|469|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1757|3|473|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1758|3|475|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1759|3|475|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1760|3|476|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1761|3|476|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1762|3|477|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1763|3|478|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1764|3|482|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1765|3|483|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1766|3|484|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1767|3|484|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1768|3|485|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1769|3|485|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1770|3|485|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1771|3|489|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1772|3|489|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1773|3|489|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1774|3|490|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1775|3|490|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1776|3|490|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1777|3|491|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1778|3|491|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1779|3|492|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1780|3|492|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1781|3|493|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1782|3|496|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1783|3|497|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1784|3|498|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1785|3|499|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1786|3|500|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1787|3|502|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1788|3|503|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1789|3|503|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1790|3|504|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1791|3|504|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1792|3|506|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1793|3|508|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1794|3|511|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1795|3|511|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1796|3|513|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1797|3|513|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1798|3|518|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1799|3|518|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1800|3|518|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1801|3|519|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1802|3|521|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1803|3|521|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1804|3|521|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1805|3|524|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1806|3|524|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1807|3|524|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1808|3|525|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1809|3|526|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBON|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1810|3|527|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1811|3|529|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1812|3|530|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1813|3|531|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1814|3|531|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1815|3|531|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1816|3|531|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1817|3|531|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1818|3|532|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1819|3|532|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1820|3|532|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1821|3|534|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1822|3|534|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1823|3|534|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1824|3|537|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1825|3|537|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1826|3|537|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1827|3|537|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1828|3|540|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1829|3|542|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1830|3|544|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1831|3|544|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1832|3|545|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1833|3|545|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1834|3|545|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1835|3|545|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1836|3|546|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1837|3|546|Neoplasia malignant|Adrenal gland  among endocrine systems|TADRC|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1838|3|547|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1839|3|547|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1840|3|547|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1841|3|548|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1842|3|550|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1843|3|552|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1844|3|552|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1845|3|553|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1846|3|553|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1847|3|553|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1848|3|554|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1849|3|555|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1850|3|557|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1851|3|558|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1852|3|558|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1853|3|559|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1854|3|559|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1855|3|560|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1856|3|560|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1857|3|560|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1858|3|560|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1859|3|561|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1860|3|561|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1861|3|561|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1862|3|561|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1863|3|561|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1864|3|562|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1865|3|563|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1866|3|564|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1867|3|564|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1868|3|565|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1869|3|566|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1870|3|566|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1871|3|566|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1872|3|567|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1873|3|567|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1874|3|568|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1875|3|568|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1876|3|569|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1877|3|572|Neoplasia malignant|Upper digestive tract,MA: 0000341 - oral region|TSQC,MPATH: 446 - squamous cell carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1878|3|573|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1879|3|573|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1880|3|574|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1881|3|574|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1882|3|574|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1883|3|575|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1884|3|575|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1885|3|575|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1886|3|576|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1887|3|576|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1888|3|576|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1889|3|576|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1890|3|576|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1891|3|578|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1892|3|580|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1893|3|580|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1894|3|580|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1895|3|580|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1896|3|581|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1897|3|581|Neoplasia malignant|Upper digestive tract,MA: 0000341 - oral region|TSQC,MPATH: 446 - squamous cell carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1898|3|582|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1899|3|582|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1900|3|582|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1901|3|583|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1902|3|583|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1903|3|583|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1904|3|583|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1905|3|584|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1906|3|585|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1907|3|586|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1908|3|587|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1909|3|587|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1910|3|587|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1911|3|588|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1912|3|589|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1913|3|589|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1914|3|589|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1915|3|590|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1916|3|590|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1917|3|590|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1918|3|590|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1919|3|592|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1920|3|593|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1921|3|593|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1922|3|593|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1923|3|594|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1924|3|594|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1925|3|594|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1926|3|594|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1927|3|594|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1928|3|595|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1929|3|595|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1930|3|595|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1931|3|595|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1932|3|596|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1933|3|597|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1934|3|597|Neoplasia malignant|Endocrine system|THARC|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1935|3|598|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1936|3|598|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1937|3|599|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1938|3|600|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1939|3|600|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1940|3|601|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1941|3|601|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1942|3|602|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1943|3|602|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1944|3|602|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1945|3|603|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1946|3|603|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1947|3|603|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TUT,MPATH: 268 - adenocarcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1948|3|604|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1949|3|604|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1950|3|605|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1951|3|605|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1952|3|605|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1953|3|607|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1954|3|607|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1955|3|608|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1956|3|608|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1957|3|609|Neoplasia benign|Endocrine system|THARA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1958|3|609|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1959|3|609|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1960|3|609|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1961|3|609|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1962|3|610|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1963|3|613|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1964|3|613|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1965|3|614|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1966|3|615|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1967|3|615|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1968|3|616|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1969|3|616|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1970|3|616|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1971|3|616|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1972|3|616|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1973|3|617|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1974|3|617|Neoplasia benign|Liver among hepato-pancreatic system diseases|THEP|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1975|3|617|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1976|3|617|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1977|3|617|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1978|3|618|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1979|3|618|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1980|3|618|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1981|3|619|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1982|3|619|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1983|3|619|Neoplasia malignant|Upper digestive tract,MA: 0000341 - oral region|TSQC,MPATH: 446 - squamous cell carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1984|3|619|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1985|3|621|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1986|3|622|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1987|3|622|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1988|3|622|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1989|3|622|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1990|3|623|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1991|3|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1992|3|623|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|TADR,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1993|3|623|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1994|3|623|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1995|3|623|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1996|3|624|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1997|3|624|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1998|3|624|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-1999|3|624|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2000|3|624|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2001|3|624|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2002|3|625|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2003|3|626|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2004|3|628|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2005|3|628|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2006|3|629|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2007|3|629|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2008|3|630|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2009|3|630|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2010|3|630|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2011|3|630|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2012|3|632|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2013|3|633|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2014|3|633|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2015|3|636|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2016|3|636|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2017|3|636|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2018|3|637|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2019|3|637|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2020|3|637|Neoplasia benign|Bloodvessels among cardiovascular system|TVASH|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2021|3|637|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2022|3|637|Neoplasia benign|Liver among hepato-pancreatic system diseases|THEP|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2023|3|637|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2024|3|638|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2025|3|639|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2026|3|639|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2027|3|639|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2028|3|639|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2029|3|640|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2030|3|641|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2031|3|641|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LSAR,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2032|3|642|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2033|3|642|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2034|3|643|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2035|3|643|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2036|3|644|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2037|3|645|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2038|3|645|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2039|3|646|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2040|3|646|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2041|3|648|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2042|3|648|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2043|3|649|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2044|3|649|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2045|3|650|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2046|3|650|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2047|3|650|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2048|3|650|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2049|3|651|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2050|3|651|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2051|3|652|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2052|3|652|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2053|3|652|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2054|3|653|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2055|3|653|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2056|3|654|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2057|3|654|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2058|3|655|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2059|3|657|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2060|3|658|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2061|3|658|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2062|3|658|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2063|3|658|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2064|3|658|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2065|3|658|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2066|3|658|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2067|3|659|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2068|3|660|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2069|3|661|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2070|3|662|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2071|3|662|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2072|3|663|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2073|3|663|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2074|3|663|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2075|3|663|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2076|3|664|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2077|3|664|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2078|3|665|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2079|3|665|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2080|3|666|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2081|3|667|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2082|3|667|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2083|3|667|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2084|3|668|Neoplasia benign|Bloodvessels among cardiovascular system|TVASH|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2085|3|668|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2086|3|669|Neoplasia benign|Endocrine system|THARA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2087|3|669|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2088|3|669|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2089|3|671|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2090|3|671|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2091|3|672|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2092|3|672|Neoplasia benign|Liver among hepato-pancreatic system diseases|THEP|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2093|3|672|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2094|3|672|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2095|3|672|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2096|3|672|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2097|3|672|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2098|3|672|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2099|3|672|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2100|3|673|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2101|3|673|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2102|3|673|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2103|3|673|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2104|3|674|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2105|3|675|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2106|3|675|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2107|3|675|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2108|3|676|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2109|3|677|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2110|3|678|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2111|3|678|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2112|3|678|Neoplasia unclassified|Lower digestive tract,MA: 0000328 - intestine|TINT,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2113|3|678|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2114|3|678|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2115|3|679|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2116|3|679|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2117|3|679|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TOTH,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2118|3|679|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2119|3|679|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2120|3|679|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2121|3|680|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2122|3|680|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2123|3|680|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2124|3|680|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2125|3|681|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2126|3|681|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2127|3|681|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2128|3|681|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2129|3|682|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2130|3|682|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2131|3|682|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2132|3|684|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2133|3|685|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2134|3|686|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2135|3|686|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2136|3|686|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2137|3|687|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2138|3|687|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2139|3|687|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2140|3|687|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2141|3|688|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2142|3|689|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2143|3|690|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2144|3|692|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2145|3|692|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2146|3|693|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2147|3|693|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2148|3|693|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2149|3|693|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2150|3|693|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2151|3|695|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2152|3|695|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2153|3|698|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2154|3|699|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2155|3|699|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2156|3|699|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2157|3|699|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2158|3|699|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2159|3|699|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2160|3|701|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2161|3|702|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2162|3|703|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2163|3|703|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2164|3|703|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2165|3|703|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2166|3|703|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2167|3|704|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2168|3|704|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2169|3|705|Neoplasia malignant|Adrenal gland  among endocrine systems|TADRC|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2170|3|706|Neoplasia benign|Liver among hepato-pancreatic system diseases|THEP|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2171|3|706|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2172|3|707|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2173|3|707|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2174|3|707|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2175|3|707|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2176|3|708|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2177|3|708|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2178|3|709|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2179|3|709|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2180|3|709|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2181|3|710|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2182|3|711|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2183|3|713|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2184|3|714|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2185|3|714|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2186|3|715|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2187|3|715|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2188|3|715|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2189|3|716|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2190|3|717|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2191|3|717|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2192|3|718|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2193|3|718|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2194|3|719|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2195|3|720|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2196|3|721|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2197|3|721|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2198|3|721|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2199|3|722|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2200|3|723|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2201|3|723|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2202|3|725|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2203|3|726|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2204|3|727|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2205|3|727|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2206|3|728|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2207|3|728|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2208|3|728|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2209|3|728|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2210|3|728|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|TADR,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2211|3|729|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2212|3|729|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2213|3|729|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2214|3|731|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LSAR,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2215|3|731|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2216|3|732|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2217|3|733|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2218|3|734|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2219|3|734|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2220|3|734|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2221|3|734|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2222|3|734|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2223|3|735|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYB,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2224|3|735|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2225|3|736|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2226|3|736|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2227|3|736|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2228|3|736|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2229|3|736|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2230|3|736|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2231|3|737|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2232|3|738|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2233|3|738|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2234|3|740|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2235|3|741|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2236|3|741|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2237|3|742|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2238|3|742|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2239|3|743|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2240|3|745|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2241|3|745|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2242|3|746|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2243|3|748|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2244|3|748|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2245|3|749|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2246|3|750|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2247|3|750|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2248|3|750|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2249|3|750|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2250|3|751|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2251|3|752|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2252|3|753|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2253|3|754|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2254|3|755|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2255|3|756|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2256|3|756|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2257|3|757|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2258|3|757|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2259|3|758|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2260|3|759|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2261|3|759|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2262|3|760|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2263|3|760|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2264|3|761|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2265|3|761|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2266|3|762|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2267|3|762|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2268|3|763|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2269|3|763|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2270|3|763|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2271|3|764|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2272|3|764|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2273|3|764|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2274|3|764|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2275|3|765|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2276|3|765|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2277|3|765|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2278|3|765|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2279|3|765|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2280|3|766|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2281|3|767|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2282|3|768|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2283|3|768|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2284|3|769|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2285|3|769|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2286|3|769|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2287|3|769|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2288|3|769|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2289|3|769|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2290|3|769|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2291|3|773|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2292|3|775|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2293|3|776|Other deterministic changes|Whole body|NVL|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2294|3|777|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2295|3|777|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2296|3|778|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2297|3|778|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2298|3|779|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2299|3|779|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2300|3|779|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2301|3|783|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2302|3|783|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2303|3|784|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2304|3|784|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2305|3|786|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2306|3|786|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2307|3|787|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2308|3|787|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2309|3|787|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2310|3|787|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2311|3|789|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2312|3|790|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2313|3|791|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2314|3|791|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2315|3|791|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2316|3|792|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2317|3|793|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2318|3|793|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2319|3|793|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2320|3|793|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2321|3|793|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2322|3|794|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2323|3|794|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2324|3|797|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2325|3|798|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2326|3|798|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2327|3|798|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2328|3|798|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2329|3|799|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2330|3|799|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|TADR,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2331|3|800|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2332|3|801|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2333|3|801|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2334|3|801|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2335|3|801|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYB,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2336|3|804|Neoplasia benign|Liver among hepato-pancreatic system diseases|THEP|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2337|3|804|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2338|3|804|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2339|3|804|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2340|3|804|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2341|3|804|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2342|3|805|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2343|3|806|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2344|3|806|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2345|3|807|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2346|3|807|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2347|3|808|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2348|3|808|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2349|3|808|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2350|3|811|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2351|3|811|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2352|3|812|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2353|3|812|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2354|3|812|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2355|3|814|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2356|3|815|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2357|3|816|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2358|3|816|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2359|3|816|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2360|3|817|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2361|3|818|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2362|3|818|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2363|3|818|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2364|3|819|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2365|3|819|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2366|3|819|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2367|3|820|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2368|3|820|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2369|3|821|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2370|3|822|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2371|3|822|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2372|3|822|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2373|3|825|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2374|3|825|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2375|3|828|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2376|3|829|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2377|3|829|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2378|3|829|Neoplasia benign|Liver among hepato-pancreatic system diseases|THEP|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2379|3|829|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2380|3|831|Neoplasia benign|Liver among hepato-pancreatic system diseases|THEP|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2381|3|832|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2382|3|832|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2383|3|835|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2384|3|835|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2385|3|838|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2386|3|838|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2387|3|838|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2388|3|838|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2389|3|838|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2390|3|839|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2391|3|840|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2392|3|840|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2393|3|840|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2394|3|842|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2395|3|842|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2396|3|843|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2397|3|845|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2398|3|846|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2399|3|847|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2400|3|848|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2401|3|848|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2402|3|849|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2403|3|853|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2404|3|853|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2405|3|854|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2406|3|859|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2407|3|860|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2408|3|862|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2409|3|862|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2410|3|863|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2411|3|865|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2412|3|867|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2413|3|868|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2414|3|868|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2415|3|869|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TOTH,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2416|3|869|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2417|3|871|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2418|3|871|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2419|3|873|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2420|3|874|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2421|3|875|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2422|3|875|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2423|3|881|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2424|3|884|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2425|3|884|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2426|3|884|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2427|3|890|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2428|3|890|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2429|3|891|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2430|3|892|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2431|3|894|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2432|3|895|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2433|3|895|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2434|3|895|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2435|3|897|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2436|3|901|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2437|3|901|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2438|3|904|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2439|3|906|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2440|3|909|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2441|3|914|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2442|3|915|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2443|3|915|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2444|3|917|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2445|3|918|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2446|3|923|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2447|3|925|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2448|3|925|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2449|3|934|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2450|3|939|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2451|3|940|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2452|3|942|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2453|3|949|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2454|3|953|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2455|3|953|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2456|3|960|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2457|3|961|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2458|3|964|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LSAR,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2459|3|966|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2460|3|968|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2461|3|969|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2462|3|976|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2463|3|981|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2464|3|988|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2465|3|988|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2466|3|990|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2467|3|993|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2468|3|995|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2469|3|996|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2470|3|1001|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2471|3|1010|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2472|3|1030|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2473|3|1031|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2474|3|1072|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-3|BALB/cBd female mice 2.0 Gy exposure at 10 weeks,BALB200A|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|809 (809 in ERA)|Mouse|Mouse, BALB/c Bd|Female|need def 11|Survival, carcinogenesis|1007-1-3-2475|3|1073|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2476|4|112|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2477|4|133|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2478|4|147|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2479|4|147|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2480|4|149|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2481|4|157|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2482|4|158|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2483|4|176|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2484|4|180|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2485|4|184|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2486|4|190|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2487|4|191|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2488|4|195|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2489|4|203|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2490|4|213|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2491|4|213|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2492|4|218|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2493|4|219|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2494|4|244|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2495|4|247|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2496|4|247|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2497|4|280|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2498|4|282|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2499|4|287|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2500|4|293|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2501|4|293|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2502|4|299|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2503|4|302|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2504|4|307|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2505|4|308|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2506|4|324|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2507|4|330|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2508|4|338|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2509|4|341|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2510|4|345|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2511|4|348|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2512|4|351|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2513|4|355|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2514|4|356|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2515|4|357|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2516|4|357|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2517|4|359|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2518|4|360|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2519|4|361|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2520|4|362|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2521|4|367|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2522|4|370|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2523|4|371|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2524|4|372|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2525|4|376|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2526|4|378|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2527|4|378|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2528|4|378|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2529|4|380|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2530|4|381|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2531|4|383|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2532|4|385|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2533|4|387|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2534|4|387|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2535|4|392|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2536|4|392|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2537|4|392|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2538|4|395|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2539|4|399|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2540|4|399|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LSAR,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2541|4|401|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2542|4|405|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2543|4|408|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2544|4|411|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2545|4|413|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2546|4|414|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2547|4|417|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2548|4|423|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2549|4|426|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2550|4|427|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2551|4|430|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2552|4|431|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2553|4|431|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2554|4|433|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2555|4|442|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2556|4|442|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2557|4|442|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2558|4|442|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2559|4|443|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2560|4|443|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2561|4|448|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2562|4|449|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2563|4|450|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2564|4|450|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2565|4|450|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2566|4|453|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2567|4|454|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2568|4|457|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2569|4|458|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2570|4|461|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2571|4|462|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2572|4|463|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2573|4|463|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2574|4|468|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2575|4|470|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2576|4|472|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2577|4|472|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2578|4|475|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2579|4|475|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2580|4|476|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2581|4|477|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2582|4|477|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2583|4|478|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2584|4|479|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2585|4|479|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2586|4|479|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2587|4|481|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2588|4|482|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2589|4|482|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2590|4|485|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2591|4|488|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2592|4|489|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2593|4|489|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2594|4|489|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2595|4|489|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2596|4|489|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2597|4|490|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2598|4|495|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2599|4|496|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2600|4|496|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2601|4|497|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2602|4|497|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2603|4|498|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2604|4|499|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2605|4|499|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2606|4|502|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2607|4|502|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2608|4|502|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2609|4|503|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2610|4|504|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2611|4|504|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2612|4|504|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2613|4|505|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2614|4|507|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2615|4|508|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2616|4|509|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2617|4|509|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2618|4|510|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2619|4|511|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2620|4|511|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2621|4|512|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2622|4|512|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2623|4|515|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2624|4|516|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2625|4|518|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2626|4|518|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2627|4|520|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2628|4|521|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2629|4|525|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2630|4|527|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2631|4|527|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPIT,MPATH: 218 - neoplasm|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2632|4|528|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2633|4|529|Neoplasia malignant|Upper digestive tract,MA: 0000341 - oral region|TSQC,MPATH: 446 - squamous cell carcinoma|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2634|4|531|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2635|4|532|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2636|4|533|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2637|4|533|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2638|4|533|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2639|4|533|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2640|4|533|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2641|4|534|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2642|4|534|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2643|4|534|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2644|4|537|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2645|4|537|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LSAR,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2646|4|538|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2647|4|538|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2648|4|539|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2649|4|541|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LSAR,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2650|4|541|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2651|4|544|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2652|4|544|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2653|4|545|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2654|4|546|Neoplasia malignant|Upper digestive tract,MA: 0000341 - oral region|TSQC,MPATH: 446 - squamous cell carcinoma|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2655|4|546|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2656|4|548|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2657|4|549|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2658|4|550|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2659|4|551|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2660|4|553|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2661|4|553|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2662|4|553|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2663|4|554|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2664|4|555|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2665|4|555|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2666|4|556|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2667|4|557|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2668|4|557|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2669|4|558|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2670|4|559|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2671|4|559|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2672|4|559|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2673|4|560|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2674|4|560|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPIT,MPATH: 218 - neoplasm|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2675|4|561|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2676|4|561|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2677|4|562|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2678|4|562|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2679|4|562|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2680|4|565|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2681|4|565|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2682|4|566|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2683|4|566|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2684|4|566|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2685|4|567|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2686|4|568|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2687|4|568|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2688|4|569|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2689|4|571|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2690|4|572|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2691|4|573|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2692|4|573|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2693|4|573|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2694|4|573|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2695|4|573|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2696|4|574|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2697|4|574|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2698|4|576|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2699|4|579|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2700|4|579|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2701|4|579|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2702|4|580|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2703|4|580|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2704|4|580|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2705|4|581|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2706|4|582|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2707|4|583|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2708|4|583|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2709|4|584|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2710|4|585|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2711|4|586|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2712|4|586|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2713|4|586|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2714|4|586|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2715|4|588|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2716|4|588|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2717|4|588|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2718|4|589|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2719|4|590|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2720|4|591|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2721|4|592|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2722|4|593|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LSAR,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2723|4|593|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2724|4|593|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2725|4|594|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2726|4|594|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2727|4|594|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2728|4|595|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2729|4|595|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2730|4|595|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2731|4|595|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2732|4|595|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2733|4|595|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2734|4|596|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2735|4|596|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2736|4|596|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2737|4|597|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2738|4|600|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2739|4|600|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2740|4|601|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2741|4|601|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2742|4|601|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2743|4|601|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2744|4|601|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2745|4|602|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2746|4|602|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2747|4|602|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2748|4|604|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2749|4|605|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2750|4|606|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2751|4|608|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2752|4|608|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2753|4|609|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2754|4|609|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2755|4|609|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2756|4|609|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2757|4|609|Neoplasia malignant|Upper digestive tract,MA: 0000341 - oral region|TSQC,MPATH: 446 - squamous cell carcinoma|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2758|4|610|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2759|4|610|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2760|4|610|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2761|4|611|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2762|4|611|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2763|4|615|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2764|4|616|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2765|4|616|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2766|4|617|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2767|4|617|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2768|4|618|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2769|4|620|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2770|4|621|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2771|4|621|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2772|4|621|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2773|4|622|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2774|4|623|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2775|4|623|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TUTE,MPATH: 268 - adenocarcinoma|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2776|4|624|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2777|4|624|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2778|4|625|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2779|4|625|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2780|4|626|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2781|4|627|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2782|4|627|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2783|4|627|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2784|4|627|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2785|4|628|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2786|4|628|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2787|4|629|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2788|4|629|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2789|4|630|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2790|4|631|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TUTE,MPATH: 268 - adenocarcinoma|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2791|4|631|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2792|4|632|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2793|4|632|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2794|4|633|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2795|4|634|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2796|4|635|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2797|4|635|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2798|4|636|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2799|4|637|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2800|4|637|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2801|4|638|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2802|4|639|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2803|4|639|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2804|4|639|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2805|4|639|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2806|4|639|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2807|4|641|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2808|4|642|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2809|4|643|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2810|4|643|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LSAR,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2811|4|643|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2812|4|643|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2813|4|643|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2814|4|644|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2815|4|645|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2816|4|645|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2817|4|645|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2818|4|645|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2819|4|646|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2820|4|647|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2821|4|648|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2822|4|650|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2823|4|651|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2824|4|651|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2825|4|652|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2826|4|652|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2827|4|652|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2828|4|652|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2829|4|653|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2830|4|654|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2831|4|655|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2832|4|657|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2833|4|657|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2834|4|657|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2835|4|658|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2836|4|658|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2837|4|658|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2838|4|659|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2839|4|659|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2840|4|662|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2841|4|663|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2842|4|663|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2843|4|663|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2844|4|664|Neoplasia malignant|Upper digestive tract,MA: 0000341 - oral region|TSQC,MPATH: 446 - squamous cell carcinoma|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2845|4|664|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2846|4|664|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2847|4|664|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2848|4|665|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2849|4|665|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2850|4|666|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2851|4|667|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2852|4|667|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2853|4|668|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2854|4|668|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2855|4|668|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2856|4|668|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2857|4|669|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2858|4|669|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2859|4|671|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2860|4|671|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2861|4|671|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2862|4|671|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2863|4|672|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2864|4|672|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2865|4|673|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2866|4|674|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2867|4|674|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LSAR,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2868|4|675|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2869|4|676|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2870|4|678|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2871|4|678|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2872|4|678|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2873|4|678|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2874|4|679|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2875|4|679|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2876|4|679|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2877|4|679|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2878|4|679|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2879|4|679|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2880|4|680|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2881|4|681|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2882|4|681|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2883|4|683|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2884|4|684|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2885|4|685|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2886|4|685|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2887|4|686|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2888|4|686|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2889|4|686|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2890|4|687|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2891|4|688|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2892|4|688|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2893|4|689|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2894|4|689|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2895|4|689|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2896|4|689|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2897|4|690|Neoplasia malignant|Upper digestive tract,MA: 0000341 - oral region|TSQC,MPATH: 446 - squamous cell carcinoma|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2898|4|691|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2899|4|692|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2900|4|692|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2901|4|692|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2902|4|692|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2903|4|693|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2904|4|693|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2905|4|693|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2906|4|693|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2907|4|694|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2908|4|694|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2909|4|694|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2910|4|695|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2911|4|699|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2912|4|699|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2913|4|699|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2914|4|699|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2915|4|699|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2916|4|699|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2917|4|700|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2918|4|700|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2919|4|701|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2920|4|701|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2921|4|701|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2922|4|702|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2923|4|703|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2924|4|703|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2925|4|703|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2926|4|705|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2927|4|705|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2928|4|705|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2929|4|705|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2930|4|706|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2931|4|706|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2932|4|706|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2933|4|706|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2934|4|707|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2935|4|707|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2936|4|707|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2937|4|707|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2938|4|708|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2939|4|708|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2940|4|708|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2941|4|708|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2942|4|708|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2943|4|708|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2944|4|709|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2945|4|709|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2946|4|710|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2947|4|710|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2948|4|710|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2949|4|711|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2950|4|711|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2951|4|713|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2952|4|713|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2953|4|713|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2954|4|714|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2955|4|714|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2956|4|714|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2957|4|715|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2958|4|719|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2959|4|720|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2960|4|720|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2961|4|720|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2962|4|721|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2963|4|721|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2964|4|722|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2965|4|722|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2966|4|722|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2967|4|722|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2968|4|722|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2969|4|723|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2970|4|723|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2971|4|723|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2972|4|725|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2973|4|727|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2974|4|727|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2975|4|727|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2976|4|727|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2977|4|728|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPIT,MPATH: 218 - neoplasm|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2978|4|728|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2979|4|728|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2980|4|729|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2981|4|729|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2982|4|729|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2983|4|730|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2984|4|730|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2985|4|730|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2986|4|730|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2987|4|731|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2988|4|731|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2989|4|731|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2990|4|731|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2991|4|731|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2992|4|733|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2993|4|734|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2994|4|734|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2995|4|734|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2996|4|735|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2997|4|737|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2998|4|737|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-2999|4|737|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3000|4|738|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3001|4|738|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3002|4|740|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3003|4|741|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3004|4|742|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3005|4|743|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3006|4|743|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3007|4|744|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3008|4|745|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3009|4|746|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3010|4|748|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3011|4|748|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3012|4|748|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3013|4|748|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3014|4|748|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3015|4|749|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3016|4|749|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3017|4|749|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3018|4|750|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3019|4|751|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3020|4|751|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3021|4|752|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3022|4|755|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3023|4|755|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3024|4|755|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3025|4|756|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3026|4|757|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3027|4|757|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3028|4|758|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3029|4|758|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3030|4|758|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3031|4|759|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3032|4|761|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3033|4|761|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3034|4|761|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3035|4|761|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3036|4|762|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3037|4|762|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3038|4|762|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3039|4|763|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3040|4|763|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3041|4|763|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3042|4|764|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3043|4|765|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3044|4|766|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3045|4|768|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3046|4|770|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3047|4|771|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3048|4|771|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3049|4|773|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3050|4|773|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3051|4|773|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3052|4|775|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3053|4|775|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LSAR,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3054|4|776|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3055|4|776|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3056|4|777|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3057|4|777|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3058|4|777|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3059|4|777|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3060|4|778|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3061|4|778|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3062|4|779|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3063|4|779|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3064|4|780|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3065|4|780|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3066|4|782|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3067|4|782|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3068|4|783|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3069|4|783|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3070|4|783|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3071|4|783|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3072|4|784|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3073|4|784|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3074|4|785|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3075|4|785|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3076|4|785|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3077|4|786|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3078|4|786|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3079|4|787|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3080|4|787|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3081|4|788|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3082|4|790|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3083|4|790|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3084|4|791|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3085|4|791|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3086|4|793|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3087|4|794|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3088|4|794|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3089|4|796|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3090|4|798|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3091|4|798|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3092|4|798|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3093|4|798|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3094|4|799|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3095|4|799|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TUTE,MPATH: 268 - adenocarcinoma|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3096|4|799|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3097|4|800|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3098|4|800|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3099|4|804|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3100|4|804|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3101|4|804|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3102|4|805|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3103|4|806|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3104|4|807|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3105|4|808|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3106|4|808|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3107|4|808|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3108|4|808|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3109|4|810|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3110|4|810|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3111|4|810|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3112|4|811|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3113|4|811|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBON|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3114|4|812|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3115|4|813|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3116|4|814|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3117|4|814|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3118|4|814|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3119|4|815|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3120|4|815|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3121|4|817|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3122|4|817|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3123|4|818|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3124|4|819|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3125|4|819|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3126|4|820|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3127|4|820|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3128|4|820|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3129|4|821|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3130|4|822|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3131|4|822|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3132|4|825|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3133|4|825|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3134|4|825|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3135|4|825|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3136|4|826|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPIT,MPATH: 218 - neoplasm|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3137|4|826|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3138|4|826|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3139|4|827|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3140|4|827|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3141|4|827|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3142|4|833|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3143|4|834|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3144|4|834|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3145|4|836|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3146|4|838|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3147|4|839|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3148|4|839|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3149|4|839|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3150|4|840|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3151|4|840|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3152|4|840|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3153|4|841|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3154|4|842|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3155|4|842|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3156|4|842|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3157|4|842|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3158|4|842|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3159|4|842|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3160|4|843|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3161|4|845|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3162|4|846|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3163|4|847|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3164|4|847|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3165|4|848|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3166|4|849|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3167|4|851|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3168|4|854|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3169|4|855|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3170|4|857|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPIT,MPATH: 218 - neoplasm|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3171|4|858|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3172|4|859|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3173|4|859|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3174|4|860|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3175|4|860|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3176|4|860|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3177|4|860|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3178|4|861|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3179|4|862|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3180|4|862|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3181|4|864|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3182|4|869|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3183|4|869|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3184|4|870|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3185|4|872|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3186|4|874|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3187|4|875|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3188|4|877|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3189|4|880|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3190|4|881|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3191|4|882|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3192|4|883|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3193|4|883|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3194|4|884|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3195|4|886|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3196|4|889|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3197|4|892|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3198|4|893|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3199|4|893|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3200|4|894|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3201|4|894|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3202|4|897|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3203|4|898|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3204|4|899|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3205|4|899|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3206|4|902|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3207|4|902|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3208|4|905|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3209|4|909|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3210|4|909|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3211|4|918|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3212|4|921|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3213|4|926|Other deterministic changes|Whole body|NVL|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3214|4|927|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3215|4|930|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3216|4|932|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3217|4|939|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3218|4|945|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3219|4|947|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-4|RFM/Bd female mice control group,RFCONTA|1|70|none (controls)|0|grays|External exposure|n/a|745 (745 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-4-3220|4|991|Neoplasia malignant|Upper digestive tract,MA: 0000341 - oral region|TSQC,MPATH: 446 - squamous cell carcinoma|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3221|5|163|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3222|5|171|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3223|5|176|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3224|5|190|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3225|5|190|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3226|5|191|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3227|5|196|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3228|5|201|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3229|5|204|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3230|5|205|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3231|5|206|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3232|5|209|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3233|5|213|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3234|5|218|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3235|5|218|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3236|5|223|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3237|5|228|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3238|5|229|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3239|5|229|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3240|5|231|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3241|5|232|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3242|5|241|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3243|5|244|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3244|5|248|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3245|5|251|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3246|5|259|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3247|5|260|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3248|5|262|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3249|5|265|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3250|5|267|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3251|5|268|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3252|5|268|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3253|5|268|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3254|5|269|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3255|5|269|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3256|5|270|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3257|5|272|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3258|5|275|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3259|5|279|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3260|5|279|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3261|5|280|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3262|5|281|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3263|5|286|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3264|5|288|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3265|5|290|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3266|5|290|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3267|5|294|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3268|5|295|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3269|5|296|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3270|5|297|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3271|5|301|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3272|5|303|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3273|5|303|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3274|5|306|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3275|5|310|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3276|5|311|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3277|5|311|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3278|5|315|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3279|5|316|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3280|5|317|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3281|5|318|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3282|5|318|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3283|5|320|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3284|5|321|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3285|5|321|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3286|5|322|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3287|5|324|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3288|5|325|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3289|5|326|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3290|5|328|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3291|5|330|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3292|5|331|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3293|5|333|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3294|5|334|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3295|5|337|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3296|5|337|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3297|5|337|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3298|5|340|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3299|5|340|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3300|5|340|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3301|5|341|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3302|5|341|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3303|5|341|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3304|5|344|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3305|5|347|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3306|5|350|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3307|5|350|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3308|5|352|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3309|5|354|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3310|5|358|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3311|5|359|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3312|5|359|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3313|5|362|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3314|5|363|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3315|5|366|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3316|5|367|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3317|5|367|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LSAR,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3318|5|372|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3319|5|374|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3320|5|376|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3321|5|377|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3322|5|377|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3323|5|378|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3324|5|378|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3325|5|378|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3326|5|378|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3327|5|379|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPIT,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3328|5|380|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3329|5|380|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3330|5|380|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3331|5|380|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3332|5|381|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3333|5|382|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3334|5|384|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3335|5|385|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3336|5|386|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3337|5|386|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3338|5|387|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3339|5|392|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3340|5|392|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3341|5|393|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3342|5|394|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3343|5|396|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3344|5|399|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3345|5|400|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3346|5|403|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3347|5|405|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3348|5|406|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3349|5|407|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3350|5|409|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3351|5|409|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3352|5|409|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3353|5|409|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3354|5|411|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3355|5|412|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3356|5|412|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3357|5|413|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3358|5|413|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3359|5|413|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3360|5|415|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3361|5|415|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LSAR,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3362|5|415|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3363|5|419|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3364|5|419|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3365|5|420|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3366|5|421|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3367|5|421|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3368|5|423|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3369|5|423|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3370|5|427|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3371|5|428|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3372|5|428|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3373|5|429|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3374|5|429|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3375|5|431|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3376|5|434|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3377|5|434|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3378|5|435|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3379|5|435|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3380|5|436|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3381|5|436|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LSAR,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3382|5|436|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3383|5|436|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3384|5|440|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3385|5|441|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3386|5|441|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3387|5|442|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3388|5|443|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3389|5|443|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3390|5|443|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3391|5|443|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3392|5|447|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3393|5|448|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3394|5|449|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3395|5|449|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3396|5|449|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3397|5|450|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3398|5|451|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3399|5|452|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3400|5|454|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3401|5|461|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3402|5|462|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3403|5|462|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3404|5|463|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3405|5|467|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3406|5|468|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3407|5|469|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3408|5|472|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3409|5|474|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3410|5|474|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3411|5|475|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3412|5|475|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3413|5|475|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3414|5|475|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3415|5|476|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3416|5|476|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3417|5|477|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3418|5|479|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3419|5|480|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3420|5|482|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3421|5|483|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3422|5|484|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3423|5|484|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3424|5|484|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3425|5|484|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3426|5|484|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3427|5|485|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3428|5|486|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3429|5|488|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3430|5|489|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3431|5|489|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3432|5|491|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3433|5|491|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3434|5|491|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3435|5|491|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3436|5|492|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3437|5|492|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3438|5|495|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3439|5|496|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3440|5|497|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3441|5|497|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3442|5|497|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3443|5|497|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3444|5|497|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3445|5|498|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3446|5|499|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3447|5|499|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3448|5|500|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3449|5|500|Neoplasia malignant|Upper digestive tract,MA: 0000341 - oral region|TSQC,MPATH: 446 - squamous cell carcinoma|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3450|5|501|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3451|5|503|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3452|5|503|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3453|5|503|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3454|5|504|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3455|5|505|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3456|5|506|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3457|5|506|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3458|5|506|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3459|5|510|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3460|5|511|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3461|5|511|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3462|5|512|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3463|5|513|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3464|5|514|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3465|5|516|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3466|5|516|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3467|5|517|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3468|5|518|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3469|5|518|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3470|5|519|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3471|5|519|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3472|5|519|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3473|5|521|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3474|5|524|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3475|5|524|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3476|5|524|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3477|5|524|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3478|5|526|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3479|5|526|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3480|5|527|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3481|5|527|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3482|5|528|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3483|5|528|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3484|5|529|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3485|5|531|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3486|5|531|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3487|5|531|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3488|5|531|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3489|5|531|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3490|5|531|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3491|5|531|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3492|5|532|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3493|5|532|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3494|5|532|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3495|5|532|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3496|5|533|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3497|5|533|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3498|5|534|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3499|5|535|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3500|5|537|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3501|5|538|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3502|5|538|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3503|5|539|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3504|5|540|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3505|5|540|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3506|5|541|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3507|5|542|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3508|5|545|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3509|5|545|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3510|5|546|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3511|5|546|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3512|5|546|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3513|5|547|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3514|5|547|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3515|5|548|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3516|5|548|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3517|5|549|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3518|5|549|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3519|5|551|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3520|5|552|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3521|5|552|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3522|5|552|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3523|5|553|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3524|5|553|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3525|5|553|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3526|5|553|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3527|5|554|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3528|5|554|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3529|5|555|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3530|5|555|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3531|5|555|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3532|5|555|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3533|5|556|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3534|5|557|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3535|5|558|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3536|5|559|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3537|5|560|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3538|5|562|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3539|5|562|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3540|5|562|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3541|5|564|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3542|5|564|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3543|5|565|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3544|5|565|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3545|5|565|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3546|5|567|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3547|5|567|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3548|5|568|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3549|5|568|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3550|5|569|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3551|5|572|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3552|5|572|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3553|5|572|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3554|5|573|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3555|5|574|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3556|5|574|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3557|5|575|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3558|5|576|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3559|5|576|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3560|5|579|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3561|5|579|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3562|5|579|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3563|5|580|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3564|5|581|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TUTE,MPATH: 268 - adenocarcinoma|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3565|5|582|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3566|5|582|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3567|5|583|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3568|5|583|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3569|5|583|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3570|5|586|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3571|5|587|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3572|5|587|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3573|5|587|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3574|5|587|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3575|5|587|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3576|5|588|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3577|5|590|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3578|5|591|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3579|5|593|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3580|5|593|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3581|5|593|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3582|5|595|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3583|5|595|Neoplasia malignant|Upper digestive tract,MA: 0000341 - oral region|TSQC,MPATH: 446 - squamous cell carcinoma|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3584|5|595|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3585|5|597|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3586|5|599|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3587|5|600|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3588|5|602|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3589|5|602|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3590|5|602|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3591|5|602|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3592|5|602|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3593|5|602|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3594|5|602|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3595|5|603|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3596|5|603|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3597|5|603|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3598|5|604|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3599|5|604|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3600|5|604|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3601|5|604|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3602|5|606|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3603|5|607|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3604|5|607|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3605|5|607|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3606|5|608|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3607|5|608|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3608|5|609|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3609|5|609|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3610|5|609|Neoplasia malignant|Upper digestive tract,MA: 0000341 - oral region|TSQC,MPATH: 446 - squamous cell carcinoma|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3611|5|610|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3612|5|612|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3613|5|613|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3614|5|614|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3615|5|614|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3616|5|615|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3617|5|615|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3618|5|615|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3619|5|615|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3620|5|615|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3621|5|615|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3622|5|616|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3623|5|616|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3624|5|616|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3625|5|617|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3626|5|617|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3627|5|618|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3628|5|620|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3629|5|621|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3630|5|621|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3631|5|624|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3632|5|624|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3633|5|625|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPIT,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3634|5|626|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3635|5|627|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3636|5|628|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3637|5|628|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3638|5|628|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3639|5|629|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3640|5|629|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3641|5|629|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3642|5|629|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3643|5|629|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3644|5|629|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3645|5|630|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3646|5|631|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3647|5|631|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3648|5|631|Neoplasia malignant|Upper digestive tract,MA: 0000341 - oral region|TSQC,MPATH: 446 - squamous cell carcinoma|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3649|5|631|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3650|5|631|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3651|5|631|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3652|5|631|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3653|5|631|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3654|5|631|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3655|5|632|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3656|5|632|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3657|5|632|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3658|5|633|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3659|5|633|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3660|5|633|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3661|5|633|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3662|5|634|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3663|5|634|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3664|5|634|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3665|5|635|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3666|5|635|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3667|5|636|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3668|5|637|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3669|5|637|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3670|5|638|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3671|5|639|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3672|5|639|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3673|5|639|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3674|5|640|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3675|5|640|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3676|5|642|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3677|5|642|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3678|5|642|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3679|5|643|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3680|5|643|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3681|5|643|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3682|5|643|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3683|5|644|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3684|5|644|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3685|5|645|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3686|5|645|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3687|5|645|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3688|5|646|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3689|5|647|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3690|5|649|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3691|5|649|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPIT,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3692|5|651|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TUTE,MPATH: 268 - adenocarcinoma|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3693|5|651|Neoplasia malignant|Upper digestive tract,MA: 0000341 - oral region|TSQC,MPATH: 446 - squamous cell carcinoma|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3694|5|652|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3695|5|652|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3696|5|655|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3697|5|655|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3698|5|655|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3699|5|656|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3700|5|656|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3701|5|658|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3702|5|658|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3703|5|659|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3704|5|659|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3705|5|660|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3706|5|662|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3707|5|662|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3708|5|663|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3709|5|663|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3710|5|663|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3711|5|663|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3712|5|664|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3713|5|664|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3714|5|664|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3715|5|665|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3716|5|665|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3717|5|666|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3718|5|667|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3719|5|667|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3720|5|667|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3721|5|669|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3722|5|669|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3723|5|670|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3724|5|670|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3725|5|671|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3726|5|671|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3727|5|671|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3728|5|672|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3729|5|672|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3730|5|673|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3731|5|673|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3732|5|674|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3733|5|675|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3734|5|677|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3735|5|678|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3736|5|678|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3737|5|679|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3738|5|680|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPIT,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3739|5|681|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3740|5|682|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3741|5|683|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3742|5|683|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3743|5|684|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3744|5|685|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3745|5|685|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3746|5|685|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3747|5|685|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3748|5|685|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3749|5|686|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3750|5|686|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3751|5|687|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3752|5|688|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3753|5|688|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3754|5|688|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3755|5|688|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3756|5|689|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3757|5|690|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3758|5|692|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3759|5|692|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3760|5|692|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3761|5|693|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3762|5|693|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3763|5|693|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3764|5|693|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3765|5|693|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3766|5|693|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3767|5|694|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3768|5|694|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3769|5|694|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3770|5|694|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3771|5|694|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3772|5|695|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3773|5|696|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3774|5|697|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3775|5|697|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3776|5|699|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3777|5|700|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3778|5|701|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3779|5|701|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3780|5|701|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3781|5|701|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3782|5|702|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3783|5|702|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3784|5|702|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3785|5|702|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3786|5|702|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3787|5|703|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3788|5|704|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3789|5|704|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3790|5|706|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3791|5|706|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3792|5|707|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3793|5|707|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3794|5|707|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3795|5|707|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3796|5|707|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3797|5|708|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3798|5|708|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3799|5|709|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3800|5|710|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3801|5|710|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3802|5|712|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3803|5|714|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3804|5|714|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3805|5|715|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3806|5|715|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3807|5|715|Neoplasia malignant|Upper digestive tract,MA: 0000341 - oral region|TSQC,MPATH: 446 - squamous cell carcinoma|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3808|5|718|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3809|5|720|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3810|5|721|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3811|5|723|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3812|5|723|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3813|5|723|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3814|5|724|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3815|5|725|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3816|5|727|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3817|5|729|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3818|5|729|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3819|5|729|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3820|5|729|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3821|5|730|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3822|5|731|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3823|5|733|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3824|5|734|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3825|5|734|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3826|5|734|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3827|5|735|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3828|5|735|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3829|5|735|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3830|5|735|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3831|5|737|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3832|5|737|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3833|5|737|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3834|5|737|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3835|5|737|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPIT,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3836|5|738|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3837|5|738|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3838|5|739|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3839|5|739|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3840|5|741|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3841|5|741|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3842|5|741|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3843|5|742|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3844|5|743|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3845|5|743|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3846|5|744|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3847|5|744|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3848|5|746|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3849|5|748|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3850|5|749|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3851|5|749|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3852|5|749|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3853|5|749|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3854|5|749|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3855|5|750|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3856|5|750|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3857|5|751|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3858|5|751|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPIT,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3859|5|752|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3860|5|752|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3861|5|752|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3862|5|755|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3863|5|755|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3864|5|755|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3865|5|756|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3866|5|756|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3867|5|756|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3868|5|756|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3869|5|756|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3870|5|757|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3871|5|757|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3872|5|758|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3873|5|759|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3874|5|759|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3875|5|762|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3876|5|763|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3877|5|764|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3878|5|764|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3879|5|765|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3880|5|765|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPIT,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3881|5|765|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3882|5|769|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3883|5|770|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3884|5|770|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3885|5|771|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3886|5|771|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3887|5|772|Neoplasia unclassified|Uterus among reproductive system diseases,MA: 0000392 - uterine cervix|TCVX,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3888|5|772|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3889|5|773|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3890|5|774|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3891|5|774|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3892|5|776|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3893|5|776|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3894|5|776|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3895|5|777|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3896|5|777|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3897|5|777|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3898|5|777|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3899|5|777|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3900|5|777|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3901|5|778|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3902|5|779|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3903|5|779|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3904|5|779|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3905|5|780|Other deterministic changes|Whole body|NVL|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3906|5|780|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3907|5|780|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3908|5|783|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3909|5|785|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3910|5|786|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3911|5|786|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3912|5|787|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3913|5|788|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3914|5|790|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3915|5|791|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3916|5|791|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3917|5|792|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3918|5|793|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3919|5|794|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3920|5|797|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3921|5|797|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3922|5|798|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3923|5|799|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3924|5|800|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3925|5|801|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3926|5|805|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3927|5|806|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3928|5|806|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3929|5|807|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3930|5|807|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3931|5|810|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3932|5|812|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3933|5|812|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3934|5|812|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3935|5|812|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3936|5|812|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3937|5|813|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3938|5|815|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3939|5|815|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3940|5|817|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3941|5|818|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3942|5|822|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3943|5|825|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3944|5|826|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3945|5|826|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3946|5|828|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3947|5|828|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3948|5|833|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3949|5|833|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3950|5|839|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3951|5|840|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3952|5|846|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3953|5|847|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3954|5|850|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3955|5|854|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3956|5|861|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3957|5|862|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3958|5|864|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3959|5|866|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3960|5|866|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3961|5|869|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3962|5|872|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3963|5|873|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3964|5|874|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3965|5|884|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3966|5|889|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3967|5|896|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-5|RFM/Bd female mice 0.5 Gy exposure at 10 weeks,RF50HA|1|70|gamma-rays Cs-137|0.5|grays|External exposure|Single exposure|748 (748 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-5-3968|5|915|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-3969|6|106|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-3970|6|113|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-3971|6|116|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-3972|6|119|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-3973|6|147|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-3974|6|154|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-3975|6|155|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-3976|6|158|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-3977|6|161|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-3978|6|164|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-3979|6|171|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-3980|6|177|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-3981|6|181|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-3982|6|183|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-3983|6|184|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-3984|6|187|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-3985|6|187|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-3986|6|188|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-3987|6|191|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-3988|6|195|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-3989|6|195|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-3990|6|196|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-3991|6|196|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-3992|6|197|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-3993|6|198|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-3994|6|198|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-3995|6|200|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-3996|6|201|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-3997|6|204|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-3998|6|205|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-3999|6|205|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4000|6|206|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4001|6|206|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4002|6|208|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4003|6|209|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4004|6|209|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4005|6|210|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4006|6|210|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4007|6|210|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4008|6|211|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4009|6|212|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4010|6|213|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4011|6|216|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4012|6|217|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4013|6|218|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4014|6|218|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4015|6|218|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4016|6|219|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4017|6|219|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4018|6|219|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4019|6|220|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4020|6|221|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4021|6|222|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4022|6|222|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4023|6|224|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4024|6|224|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4025|6|224|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4026|6|225|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4027|6|225|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4028|6|225|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4029|6|226|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4030|6|226|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4031|6|229|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4032|6|230|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4033|6|230|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4034|6|230|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4035|6|231|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4036|6|231|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4037|6|232|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4038|6|232|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4039|6|232|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4040|6|232|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4041|6|233|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4042|6|233|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4043|6|235|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4044|6|236|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4045|6|236|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4046|6|238|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4047|6|238|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4048|6|239|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4049|6|241|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4050|6|244|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4051|6|244|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4052|6|244|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4053|6|245|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4054|6|246|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4055|6|247|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4056|6|247|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4057|6|247|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4058|6|247|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4059|6|248|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4060|6|249|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4061|6|249|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4062|6|249|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4063|6|250|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4064|6|250|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4065|6|251|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4066|6|251|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4067|6|252|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBON|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4068|6|252|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4069|6|253|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4070|6|253|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4071|6|253|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4072|6|253|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4073|6|253|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4074|6|253|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4075|6|253|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4076|6|254|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4077|6|254|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4078|6|255|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4079|6|257|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4080|6|259|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4081|6|259|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4082|6|260|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4083|6|261|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4084|6|261|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4085|6|262|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4086|6|262|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4087|6|262|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4088|6|265|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4089|6|266|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4090|6|268|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4091|6|269|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4092|6|270|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4093|6|270|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4094|6|270|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4095|6|271|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4096|6|271|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4097|6|271|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4098|6|272|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4099|6|272|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4100|6|272|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4101|6|272|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4102|6|272|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4103|6|272|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4104|6|272|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4105|6|273|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4106|6|274|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4107|6|275|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4108|6|275|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4109|6|275|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4110|6|279|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4111|6|280|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4112|6|280|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4113|6|281|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4114|6|281|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4115|6|283|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4116|6|287|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4117|6|288|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4118|6|288|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4119|6|288|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4120|6|289|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4121|6|289|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4122|6|290|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4123|6|291|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4124|6|293|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4125|6|294|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4126|6|299|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4127|6|299|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4128|6|299|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4129|6|299|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4130|6|302|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4131|6|302|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4132|6|303|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4133|6|304|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4134|6|304|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4135|6|304|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4136|6|307|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4137|6|307|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4138|6|308|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4139|6|309|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4140|6|309|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4141|6|309|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4142|6|310|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4143|6|310|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4144|6|310|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4145|6|311|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4146|6|311|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4147|6|314|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4148|6|314|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4149|6|315|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4150|6|315|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4151|6|318|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4152|6|319|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4153|6|322|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4154|6|323|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4155|6|323|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4156|6|323|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4157|6|324|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4158|6|324|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4159|6|324|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4160|6|325|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4161|6|328|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4162|6|329|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4163|6|330|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4164|6|331|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4165|6|331|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4166|6|335|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4167|6|336|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4168|6|336|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4169|6|337|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4170|6|337|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4171|6|340|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4172|6|340|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4173|6|342|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4174|6|342|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4175|6|343|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4176|6|343|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4177|6|344|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4178|6|345|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4179|6|346|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4180|6|347|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4181|6|348|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4182|6|349|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4183|6|349|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4184|6|350|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4185|6|350|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4186|6|350|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4187|6|351|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4188|6|351|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4189|6|351|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4190|6|351|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4191|6|352|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4192|6|353|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4193|6|353|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4194|6|353|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4195|6|356|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4196|6|356|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4197|6|356|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4198|6|356|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4199|6|357|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4200|6|358|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4201|6|359|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4202|6|359|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPIT,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4203|6|359|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4204|6|362|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4205|6|364|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4206|6|365|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4207|6|365|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4208|6|365|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4209|6|366|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4210|6|371|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4211|6|371|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4212|6|371|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4213|6|373|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4214|6|374|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4215|6|374|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4216|6|375|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4217|6|376|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4218|6|377|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4219|6|379|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4220|6|379|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4221|6|379|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4222|6|379|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4223|6|380|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4224|6|380|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4225|6|380|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4226|6|382|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4227|6|382|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4228|6|386|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4229|6|386|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4230|6|393|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4231|6|393|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4232|6|393|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4233|6|393|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4234|6|393|Neoplasia benign|Endocrine system|THARA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4235|6|394|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4236|6|396|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4237|6|396|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4238|6|398|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4239|6|398|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4240|6|398|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4241|6|399|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4242|6|400|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4243|6|401|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4244|6|405|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4245|6|406|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4246|6|406|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4247|6|406|Neoplasia malignant|Upper digestive tract,MA: 0000341 - oral region|TSQC,MPATH: 446 - squamous cell carcinoma|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4248|6|406|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4249|6|406|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4250|6|407|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4251|6|407|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4252|6|407|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4253|6|409|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4254|6|409|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4255|6|409|Neoplasia malignant|Upper digestive tract,MA: 0000341 - oral region|TSQC,MPATH: 446 - squamous cell carcinoma|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4256|6|409|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4257|6|414|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4258|6|414|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4259|6|415|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4260|6|416|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4261|6|417|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4262|6|418|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4263|6|419|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4264|6|420|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4265|6|420|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4266|6|421|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4267|6|421|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4268|6|421|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4269|6|422|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4270|6|423|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4271|6|423|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4272|6|424|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4273|6|426|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4274|6|426|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4275|6|426|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4276|6|427|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4277|6|428|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4278|6|428|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4279|6|429|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4280|6|430|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4281|6|430|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4282|6|433|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4283|6|433|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4284|6|433|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4285|6|435|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4286|6|435|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4287|6|435|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4288|6|436|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4289|6|437|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TOTH,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4290|6|437|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4291|6|437|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4292|6|437|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LSAR,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4293|6|440|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4294|6|440|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4295|6|441|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4296|6|441|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4297|6|441|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4298|6|443|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4299|6|447|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4300|6|447|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4301|6|447|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4302|6|447|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4303|6|449|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4304|6|449|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4305|6|450|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4306|6|451|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4307|6|454|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4308|6|454|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4309|6|454|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4310|6|454|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBON|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4311|6|455|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4312|6|457|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4313|6|461|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4314|6|461|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4315|6|461|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4316|6|462|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4317|6|462|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4318|6|462|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4319|6|464|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4320|6|464|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4321|6|465|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4322|6|465|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4323|6|466|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4324|6|468|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4325|6|472|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4326|6|472|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4327|6|476|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4328|6|476|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4329|6|476|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4330|6|476|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4331|6|477|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4332|6|477|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4333|6|479|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4334|6|481|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4335|6|481|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4336|6|481|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4337|6|482|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4338|6|482|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4339|6|484|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4340|6|484|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4341|6|485|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4342|6|487|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4343|6|488|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4344|6|489|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4345|6|490|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4346|6|495|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4347|6|495|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4348|6|496|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4349|6|496|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4350|6|497|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4351|6|497|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4352|6|499|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4353|6|499|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4354|6|499|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4355|6|499|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4356|6|499|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBON|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4357|6|500|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4358|6|501|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4359|6|502|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4360|6|502|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4361|6|503|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4362|6|506|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4363|6|507|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4364|6|507|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4365|6|507|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4366|6|510|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4367|6|510|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4368|6|511|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4369|6|512|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4370|6|512|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4371|6|513|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4372|6|515|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4373|6|517|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4374|6|518|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4375|6|519|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4376|6|519|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4377|6|520|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4378|6|520|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4379|6|522|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4380|6|524|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4381|6|524|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4382|6|524|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4383|6|525|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4384|6|526|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4385|6|526|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4386|6|526|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4387|6|527|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4388|6|527|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4389|6|527|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4390|6|527|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4391|6|530|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4392|6|530|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4393|6|532|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4394|6|532|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4395|6|532|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4396|6|534|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4397|6|535|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4398|6|535|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4399|6|535|Neoplasia malignant|Upper digestive tract,MA: 0000341 - oral region|TSQC,MPATH: 446 - squamous cell carcinoma|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4400|6|538|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4401|6|538|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4402|6|538|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4403|6|539|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4404|6|539|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4405|6|540|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4406|6|540|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4407|6|540|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4408|6|541|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4409|6|541|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4410|6|542|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4411|6|542|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4412|6|543|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4413|6|543|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4414|6|543|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4415|6|544|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4416|6|544|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4417|6|544|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4418|6|545|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4419|6|545|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4420|6|545|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4421|6|546|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4422|6|546|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4423|6|546|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4424|6|546|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4425|6|546|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4426|6|547|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4427|6|547|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4428|6|548|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4429|6|549|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4430|6|551|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4431|6|553|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4432|6|553|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4433|6|553|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPIT,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4434|6|554|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4435|6|554|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4436|6|554|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4437|6|554|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4438|6|555|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4439|6|556|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4440|6|558|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4441|6|559|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4442|6|559|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4443|6|559|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4444|6|560|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4445|6|560|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4446|6|560|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4447|6|560|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4448|6|561|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4449|6|562|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4450|6|565|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4451|6|566|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4452|6|566|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4453|6|567|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4454|6|567|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4455|6|568|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4456|6|568|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4457|6|572|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4458|6|572|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4459|6|572|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4460|6|573|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4461|6|573|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4462|6|573|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4463|6|574|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4464|6|574|Neoplasia benign|Bloodvessels among cardiovascular system|TVASH|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4465|6|574|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4466|6|577|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4467|6|578|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4468|6|580|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4469|6|580|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4470|6|581|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4471|6|581|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4472|6|582|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4473|6|584|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4474|6|587|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4475|6|588|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4476|6|588|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4477|6|588|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4478|6|589|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4479|6|590|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4480|6|590|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4481|6|591|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4482|6|591|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4483|6|591|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4484|6|594|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4485|6|594|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4486|6|596|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4487|6|596|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4488|6|597|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4489|6|598|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4490|6|599|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4491|6|599|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4492|6|600|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4493|6|600|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4494|6|601|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4495|6|602|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4496|6|602|Neoplasia malignant|Endocrine system|THARC|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4497|6|603|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4498|6|603|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4499|6|604|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4500|6|605|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4501|6|605|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4502|6|605|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4503|6|607|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4504|6|607|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4505|6|608|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4506|6|608|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4507|6|611|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4508|6|611|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4509|6|614|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4510|6|616|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4511|6|616|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4512|6|616|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4513|6|617|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4514|6|617|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4515|6|617|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4516|6|617|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4517|6|618|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4518|6|618|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4519|6|618|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TUTE,MPATH: 268 - adenocarcinoma|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4520|6|619|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4521|6|619|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4522|6|620|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4523|6|621|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TBST,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4524|6|621|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4525|6|622|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4526|6|622|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4527|6|622|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4528|6|623|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4529|6|623|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4530|6|624|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4531|6|624|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|TADR,MPATH: 549 - carcinoma|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4532|6|624|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4533|6|624|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4534|6|625|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4535|6|625|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4536|6|626|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4537|6|627|Neoplasia malignant|Bloodvessels among cardiovascular system|TVASS|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4538|6|628|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4539|6|628|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4540|6|629|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4541|6|629|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4542|6|629|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4543|6|629|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4544|6|631|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4545|6|631|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4546|6|631|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4547|6|631|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPIT,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4548|6|633|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4549|6|633|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4550|6|634|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4551|6|634|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4552|6|635|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4553|6|635|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4554|6|635|Neoplasia unclassified|Kidney among urinary system diseases,MA: 0000368 - kidney|TKID,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4555|6|636|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4556|6|636|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4557|6|638|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4558|6|639|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4559|6|640|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4560|6|640|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4561|6|640|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4562|6|642|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4563|6|642|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4564|6|643|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4565|6|643|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4566|6|644|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4567|6|644|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4568|6|645|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4569|6|645|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4570|6|648|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4571|6|649|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4572|6|650|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4573|6|650|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4574|6|650|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LTHY,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4575|6|650|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4576|6|651|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4577|6|651|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4578|6|652|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPIT,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4579|6|653|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4580|6|654|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4581|6|656|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4582|6|657|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4583|6|657|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4584|6|657|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4585|6|658|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4586|6|658|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4587|6|660|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4588|6|661|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4589|6|663|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4590|6|664|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4591|6|664|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4592|6|667|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4593|6|667|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4594|6|667|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4595|6|667|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4596|6|668|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4597|6|668|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4598|6|669|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4599|6|672|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4600|6|672|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4601|6|673|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4602|6|674|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4603|6|674|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4604|6|674|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4605|6|674|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4606|6|675|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4607|6|677|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4608|6|678|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4609|6|678|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4610|6|680|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4611|6|681|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4612|6|681|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4613|6|682|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4614|6|682|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4615|6|682|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4616|6|682|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4617|6|685|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4618|6|685|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4619|6|686|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4620|6|686|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4621|6|687|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4622|6|687|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4623|6|688|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4624|6|688|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4625|6|689|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4626|6|690|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4627|6|690|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4628|6|693|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LLYM,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4629|6|693|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4630|6|693|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4631|6|693|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4632|6|693|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4633|6|693|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4634|6|694|Neoplasia benign|Bloodvessels among cardiovascular system|TVASH|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4635|6|695|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4636|6|695|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4637|6|697|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4638|6|698|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4639|6|699|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4640|6|699|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4641|6|701|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPIT,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4642|6|702|Neoplasia benign|Bloodvessels among cardiovascular system|TVASH|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4643|6|702|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4644|6|702|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4645|6|702|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4646|6|703|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4647|6|713|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4648|6|713|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4649|6|713|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4650|6|713|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4651|6|714|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4652|6|716|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4653|6|719|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4654|6|719|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TLUNC,MPATH: 549 - carcinoma|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4655|6|720|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4656|6|720|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4657|6|721|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4658|6|721|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4659|6|721|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4660|6|722|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|TADR,MPATH: 549 - carcinoma|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4661|6|724|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4662|6|724|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4663|6|727|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4664|6|728|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4665|6|728|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4666|6|728|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4667|6|730|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4668|6|730|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4669|6|731|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4670|6|731|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4671|6|734|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4672|6|734|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4673|6|734|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4674|6|735|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4675|6|735|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4676|6|735|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TUTE,MPATH: 268 - adenocarcinoma|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4677|6|737|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4678|6|737|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4679|6|741|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4680|6|741|Other deterministic changes|Whole body|NVL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4681|6|742|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4682|6|743|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4683|6|747|Neoplasia systemic|Haematolymphatic system|LMYL|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4684|6|749|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4685|6|750|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4686|6|752|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4687|6|754|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4688|6|755|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4689|6|757|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4690|6|757|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4691|6|759|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4692|6|761|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4693|6|762|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4694|6|763|Neoplasia malignant|Other local manifestations and miscellaneus|TSAR|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4695|6|766|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4696|6|768|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4697|6|768|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4698|6|769|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4699|6|770|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4700|6|770|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4701|6|770|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4702|6|771|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4703|6|773|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4704|6|779|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4705|6|779|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4706|6|780|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4707|6|784|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4708|6|786|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4709|6|786|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4710|6|787|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4711|6|789|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4712|6|791|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4713|6|793|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4714|6|800|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4715|6|804|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4716|6|815|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4717|6|817|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4718|6|818|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4719|6|820|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4720|6|828|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4721|6|831|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4722|6|840|Neoplasia benign|Lower respiratory system|TLUNA|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4723|6|840|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4724|6|861|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4725|6|861|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPIT,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4726|6|862|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOV,MPATH: 218 - neoplasm|
1007-1-6|RFM/Bd female mice 2.0 Gy exposure at 10 weeks,RF200HA|1|70|gamma-rays Cs-137|2|grays|External exposure|Single exposure|759 (759 in ERA)|Mouse|Mouse, BFM|Female|need def 11|Survival, carcinogenesis|1007-1-6-4727|6|953|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|LRCS,MPATH: 513 - Lymphoid neoplasms|
